Medifast (MED) Beats Q3 Earnings and Revenue Estimates
- Medifast (MED) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $2.12 per share a year ago.
- 11/04/2024
|
Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Jim Salera - Stephens Inc. Linda Bolton-Weiser - D.A. Davidson Operator Greetings, and welcome to the Medifast Third Quarter 2024 Earnings Conference Call.
- 11/04/2024
|
Medifast Gears Up for Q3 Earnings: Here's What You Should Know
- MED's Q3 results may reflect customer acquisition challenges and a decline in active earning OPTAVIA Coaches due to the increasing adoption of GLP-1 medications.
- 11/01/2024
|
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
- BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Offi.
- 10/21/2024
|
Medifast Drives Growth With Weight Loss Transformation Strategies
- MED is striving to excel in the evolving weight loss market where GLP-1 medication adoption is reshaping the industry dynamics amid macroeconomic challenges.
- 10/07/2024
|
The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
- LOS ANGELES, CA / ACCESSWIRE / October 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 10/03/2024
|
Medifast Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Reach Out To The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / October 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 10/02/2024
|
The Schall Law Firm Urges Shareholders To Join An Inquiry Into Medifast, Inc. For Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / October 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 10/01/2024
|
Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/30/2024
|
The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
- LOS ANGELES, CA / ACCESSWIRE / September 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/29/2024
|
Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/28/2024
|
The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
- LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/27/2024
|
Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/26/2024
|
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/25/2024
|
Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/24/2024
|
The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
- LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/23/2024
|
Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / September 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/22/2024
|
The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Medifast, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/21/2024
|
Medifast Inc May Have Violated Securities Laws And Investors Are Urged To Help The Schall Law Firm Investigate
- LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/20/2024
|
The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/19/2024
|
Medifast Inc Is Being Investigated By The Schall Law Firm For Securities Law Violations And Investors Are Invited To Lend A Hand
- LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/18/2024
|
The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.
- LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/17/2024
|
Investors With Losses In Medifast Inc Are Urged To Help The Schall Law Firm Investigate Possible Securities Law Violations
- LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/16/2024
|
Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry
- LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/15/2024
|
The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake
- LOS ANGELES, CA / ACCESSWIRE / September 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/14/2024
|
Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry
- LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/13/2024
|
Medifast Trades Near 52-Week Low: Buy, Hold or Sell MED Stock?
- Amid hurdles like competition and a dynamic consumer landscape, Medifast is taking steps to realign its strategy and capitalize on emerging opportunities.
- 09/12/2024
|
The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/12/2024
|
Medifast, Inc. May Have Committed Securities Fraud And Shareholders Can Join The Schall Law Firm's Inquiry
- LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/11/2024
|
The Schall Law Firm Is Looking Into Medifast Inc For Possible Securities Law Violations And Investors With Losses Should Reach Out
- LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/10/2024
|
Medifast, Inc. Might Have Committed Securities Fraud And Impacted Shareholders Can Join The Schall Law Firm's Inquiry
- LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/09/2024
|
The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation
- LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/07/2024
|
Stakeholders With Losses In Medifast, Inc. Are Urged By The Schall Law Firm To Reach Out About An Inquiry Into Securities Law Violations
- LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/06/2024
|
Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation
- LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/05/2024
|
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out
- LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/04/2024
|
Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation
- LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/03/2024
|
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Regulations And The Public Is Invited To Join
- LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/02/2024
|
Medifast Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Seeks Shareholder Participation
- LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/01/2024
|
An Inquiry By The Schall Law Firm Has Been Launched Into Medifast Inc. For Violating Securities Regulations And Affected Investors Should Reach Out
- LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/31/2024
|
Medifast Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Urges Individuals With Losses To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/30/2024
|
The Schall Law Firm Has Launched An Inquiry Into Medifast Inc. For Violating Securities Regulations And Investors Can Take Part
- LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/29/2024
|
Medifast Being Investigated on Behalf of Medifast, Inc. Investors. Contact Levi & Korsinsky For Details
- NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/29/2024
|
Medifast Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/28/2024
|
Medifast, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - MED
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/28/2024
|
Investors Are Invited By The Schall Law Firm To Participate In An Inquiry Into Medifast Inc For Securities Law Violations
- LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/27/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Medifast, Inc. (MED) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/27/2024
|
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
- Medifast (MED) is making efforts to thrive in the rapidly evolving weight loss market, as the adoption of GLP-1 medications reshapes industry dynamics.
- 08/26/2024
|
Medifast Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Join
- LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/26/2024
|
An Investigation Has Commenced on Behalf of Medifast, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MED Losses.
- NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/25/2024
|
The Schall Law Firm Has Launched An Inquiry Into Medifast Inc And The Firm Is Seeking Investors To Participate
- LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/25/2024
|
MED ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Medifast, Inc. investment
- NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/24/2024
|
A Securities Fraud Investigation Of Medifast Inc Has Been Opened By The Schall Law Firm And Stockholders Are Urged To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/24/2024
|
Medifast, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Medifast (MED)
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/23/2024
|
The Schall Law Firm Is Inquiring Into Medifast Inc. For Potential Securities Law Violations And Impacted Investors Are Encouraged To Participate
- LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/23/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Medifast, Inc. (MED) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/22/2024
|
Medifast Inc. Is Being Investigated By The Schall Law Firm For Possible Securities Fraud And Affected Shareholders Are Invited To Join
- LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/22/2024
|
Medifast, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - MED
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/21/2024
|
Lost Money on Medifast, Inc. (MED)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/20/2024
|
The Schall Law Firm Is Investigating Medifast Inc. For Possible Securities Fraud And Invites Shareholders To Help
- LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/20/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Medifast, Inc. (MED)
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/19/2024
|
Shareholders that lost money on Medifast, Inc.(MED) should contact Levi & Korsinsky about Securities Fraud Investigation - MED
- NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/18/2024
|
The Schall Law Firm Is Inquiring Into Claims Against Medifast, Inc. And Invites Shareholder Participation
- LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/18/2024
|
Shareholders that lost money on Medifast, Inc.(MED) should contact Levi & Korsinsky about Securities Fraud Investigation - MED
- NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/17/2024
|
Did Medifast, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - MED
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/16/2024
|
The Schall Law Firm Is Investigating Medifast, Inc. And Seeks Investor Participation
- LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/16/2024
|
Shareholders That Lost Money on Medifast, Inc. (MED) Should Contact Levi & Korsinsky About Securities Fraud Investigation - MED
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of federal securities laws. Medifast reported its quarterly earnings on April 29, 2024.
- 08/16/2024
|
The Schall Law Firm Is Opening An Investigation Into Medifast, Inc. And Encourages Investor Participation
- LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/15/2024
|
The Schall Law Firm Announces An Investigation Into Claims Against Medifast, Inc. And Invites Investor Participation
- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/14/2024
|
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
- Medifast (MED) is encountering difficulties in attracting customers due to a reduction in the number of active OPTAVIA Coaches and diminished productivity per Coach.
- 08/14/2024
|
Medifast (MED) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
- Medifast's (MED) Q2 results highlight the challenges of poor customer acquisition. However, the company is focusing strategically on medically supported weight loss, indicating potential for growth.
- 08/06/2024
|
Medifast, Inc. (MED) Q2 2024 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants James Salera - Stephens Linda Bolton-Weiser - D.A. Davidson David Larsen - BTIG Operator And welcome to the Medifast Second Quarter 2024 Earnings Conference Call.
- 08/05/2024
|
Medifast (MED) Q2 Earnings and Revenues Beat Estimates
- Medifast (MED) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $2.77 per share a year ago.
- 08/05/2024
|
Medifast Announces Second Quarter 2024 Financial Results
- BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenue of $168.6 million, with revenue per active earning Coach of $4,972 Independent active earning OPTAVIA Coaches of 33,900 Net loss of $8.2 million (non-GAAP adjusted net income of $10.1 million) Loss per diluted share of $0.75 (non-GAAP adjusted earni.
- 08/05/2024
|
Medifast (MED) Q2 Earnings in the Cards: Factors to Watch
- Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.
- 08/02/2024
|
Time to Unload: 3 Stocks in Deep Trouble to Sell Now
- The end of the pandemic served as a springboard for the economy, launching us into a new bull market. I can't blame people for being optimistic after seeing the meteoric rise of several big-name stocks.
- 07/22/2024
|
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
- For the last two years, investors in consumer staples stocks saw every tiny step forward smacked down by two large steps back. Therefore, the 900+-point gain in the Dow Jones Industrial Average (DJIA) the week of July 15 was noteworthy.
- 07/19/2024
|
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
- While Medifast (MED) is implementing a series of measures to propel its growth trajectory, the challenges related to customer acquisition and high marketing expenses keep it in a tight spot.
- 07/16/2024
|
Investor Participation Is Invited As The Schall Law Firm Announces An Investigation Into Claims Against Medifast, Inc.
- LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 07/03/2024
|
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
- Low-priced stocks to buy with the potential to double within the next year or so have inherent appeal for investors. Individual shares are affordable making it relatively easy to establish a stake.
- 06/28/2024
|
3 Stocks to Sell as Ozempic Surges in Popularity
- Novo Nordisk's (NYSE: NVO ) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest mega-blockbuster drug. Yet, while you may be thinking about ways to capitalize on its popularity and the rise of other glucagon-like peptide-1 (GLP-1) weight loss treatments, you should also consider the stocks to sell because of this trend.
- 06/14/2024
|
7 Small-Cap Value Stocks Leaving the S&P 500 in the Dust
- Even as the S&P 500 reaches new highs, some investors view small-cap value stocks as the best option for long-term growth. Concerns are growing about the concentration of investments in index-based stocks.
- 06/12/2024
|
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
- Medifast (MED) battles persistent customer acquisition challenges aggravated by macroeconomic factors and the rising popularity of weight loss medications.
- 06/11/2024
|
The Schall Law Firm Is Initiating An Investigation Into Accusations Against Medifast, Inc. And Urges Investor Engagement
- LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/09/2024
|
The Schall Law Firm Announces A Probe Into Allegations Against Medifast, Inc. And Encourages Investor Involvement
- LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/08/2024
|
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
- NEW YORK , June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range.
- 06/07/2024
|
The Schall Law Firm Declares An Investigation Into Claims Against Medifast, Inc. And Invites Investor Participation
- LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/07/2024
|
The Schall Law Firm Announces An Inquiry Into Allegations Against Medifast, Inc. And Encourages Investor Engagement
- LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/06/2024
|
The Schall Law Firm Proclaims an Investigation into Accusations Against Medifast, Inc. and Urges Investor Communication
- LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/04/2024
|
MED INVESTIGATION PROGRESS UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/03/2024
|
INVESTIGATION PROGRESS UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/02/2024
|
INVESTIGATION PROGRESS ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 06/01/2024
|
INVESTIGATION PROGRESS REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/31/2024
|
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/30/2024
|
7 Underappreciated Stocks With 25% Return Potential in 2024
- Whether investors refer to them as undervalued or hidden gems, underappreciated stocks are always worth considering. Investors have made fortunes, large and small, by identifying underappreciated shares and investing their capital.
- 05/30/2024
|
Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong
- As inflation remains increasingly sticky, finding undervalued stocks to buy has become increasingly difficult. Meme stocks like GameStop (NYSE: GME ) continue climbing despite rapidly approaching market saturation, which could leave retail traders holding the bag when the music stops.
- 05/20/2024
|
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
- BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA's new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program, a holistic approach to medical weight loss specifically tailored to support the needs of those utilizing GLP-1 medications. This rob.
- 05/20/2024
|
Zacks Research Weighs in on Medifast, Inc.’s Q2 2024 Earnings (NYSE:MED)
- Medifast, Inc. (NYSE:MED – Free Report) – Stock analysts at Zacks Research issued their Q2 2024 earnings per share estimates for Medifast in a report issued on Thursday, May 16th. Zacks Research analyst A. Mohta expects that the specialty retailer will earn $0.32 per share for the quarter. The consensus estimate for Medifast’s current full-year earnings is $0.95 per share. Zacks Research also issued estimates for Medifast’s Q3 2024 earnings at $0.14 EPS, Q4 2024 earnings at $0.21 EPS, FY2024 earnings at $1.33 EPS, Q1 2025 earnings at $0.58 EPS, Q2 2025 earnings at $0.64 EPS, Q3 2025 earnings at $0.53 EPS, Q4 2025 earnings at $0.62 EPS, FY2025 earnings at $2.37 EPS, Q1 2026 earnings at $0.89 EPS and FY2026 earnings at $3.16 EPS. Medifast (NYSE:MED – Get Free Report) last posted its quarterly earnings results on Monday, April 29th. The specialty retailer reported $0.66 EPS for the quarter, missing analysts’ consensus estimates of $0.78 by ($0.12). Medifast had a return on equity of 36.64% and a net margin of 7.55%. The company had revenue of $174.74 million during the quarter, compared to the consensus estimate of $168.90 million. During the same period in the previous year, the business earned $3.67 earnings per share. Medifast’s revenue was down 49.9% on a year-over-year basis. MED has been the topic of a number of other research reports. DA Davidson lowered their price objective on Medifast from $40.00 to $25.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 30th. TheStreet downgraded Medifast from a “c” rating to a “d+” rating in a research report on Wednesday, February 21st. View Our Latest Analysis on Medifast Medifast Stock Performance Shares of MED stock opened at $25.00 on Monday. Medifast has a 52-week low of $24.58 and a 52-week high of $109.52. The company has a market capitalization of $273.50 million, a PE ratio of 4.03 and a beta of 1.19. The business’s fifty day moving average is $32.08 and its 200 day moving average is $49.90. Insider Buying and Selling at Medifast In other news, Director Scott Schlackman sold 4,053 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $39.44, for a total transaction of $159,850.32. Following the transaction, the director now directly owns 7,785 shares of the company’s stock, valued at $307,040.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.06% of the company’s stock. Institutional Inflows and Outflows A number of institutional investors and hedge funds have recently modified their holdings of MED. Bank of New York Mellon Corp grew its stake in shares of Medifast by 2.1% during the third quarter. Bank of New York Mellon Corp now owns 194,369 shares of the specialty retailer’s stock valued at $14,549,000 after buying an additional 4,005 shares during the last quarter. TD Asset Management Inc grew its stake in shares of Medifast by 35.8% during the third quarter. TD Asset Management Inc now owns 9,100 shares of the specialty retailer’s stock valued at $681,000 after buying an additional 2,400 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Medifast by 32.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 8,984 shares of the specialty retailer’s stock worth $672,000 after purchasing an additional 2,188 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Medifast by 112.6% in the third quarter. Nisa Investment Advisors LLC now owns 7,281 shares of the specialty retailer’s stock worth $545,000 after purchasing an additional 3,857 shares during the last quarter. Finally, Olympiad Research LP bought a new stake in shares of Medifast in the third quarter worth about $208,000. 95.51% of the stock is owned by institutional investors. About Medifast (Get Free Report) Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. Read More Five stocks we like better than Medifast Why Understanding Call Option Volume is Essential to Successful Options Trading MarketBeat Week in Review – 5/13 – 5/17 CD Calculator: Certificate of Deposit Calculator Take-Two Interactive Software Offers 2nd Chance for Investors Canadian Penny Stocks: Can They Make You Rich? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
- 05/20/2024
|
Readers Identify 23 Ideal April Dividend Buys
- Prior to April 30, 2024, my Readers mentioned 31 equities in their comments on my articles. Some bad-news investments (Rogues) mixed with (mostly) Favorites. Thus, they remarked about the ReFa/Ro. Ten analyst-target-estimated top net gain ReFa/Ro: ORC, JNJ, CVX, FTN.CA, OXLC, ACRE, MED, RC, INTC, and VFC averaged 22.94% net gains from reader data collected 5/15/23. Ten analyst-target-augured April top price upside reader faves & rogues (ReFa/Ro) were: ORI, O, KVUE, PFE, WES, CVX, JNJ, RC, INTC & VFC boasting a 16.43% average target price upside estimate.
- 05/19/2024
|
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/19/2024
|
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/18/2024
|
IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/17/2024
|
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/16/2024
|
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/15/2024
|
Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar
- As the S&P 500 races toward new highs, some investors see small-cap value stocks as the best bet for long-term growth amid growing concerns about index-based stock concentration. As mega-caps like Nvidia (NASDAQ: NVDA ) disproportionately drive the S&P 500's performance, the index becomes more vulnerable to fluctuations—a few missteps could significantly impact your entire portfolio.
- 05/13/2024
|
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/09/2024
|
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / May 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 05/06/2024
|
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / April 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 04/30/2024
|
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
- Medifast's (MED) first-quarter results reflect challenges related to a decline in active earning OPTAVIA Coaches, lower coach productivity and soft sales volume.
- 04/30/2024
|
Why Is Medifast (MED) Stock Down 20% Today?
- Medifast (NYSE: MED ) stock is falling on Tuesday after the weight loss company released its earnings report for the first quarter of 2024. The bad news for MED stock comes from its adjusted earnings per share of 66 cents.
- 04/30/2024
|
Medifast, Inc. (MED) Q1 2024 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q1 2024 Earnings Call Transcript April 29, 2024 4:30 PM ET Company Participants Steven Zenker - VP, IR Dan Chard - Chairman & CEO James Maloney - CFO Conference Call Participants James Salera - Stephens Linda Bolton-Weiser - D.A. Davidson Operator Greetings.
- 04/29/2024
|
Medifast Announces First Quarter 2024 Financial Results
- BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 Revenue of $174.7 million, with revenue per active earning coach of $4,623 Independent active earning OPTAVIA Coaches of 37,800 Net income of $8.3 million (non-GAAP adjusted net income of $7.2 million) Earnings per diluted share ("EPS") of $0.76 (non-GAAP ad.
- 04/29/2024
|
65 Graham Value Stocks: 54 Fit To Buy For April
- Large Cap Value is a value ranking for large cap stocks that looks at the price of a stock relative to measurements of intrinsic firm value. The Ben Graham Formula strategy selects ultra-stable stocks based on criteria such as sales, earnings, and dividend payments. 54 out of 65 All-Star-Value Dividend stocks offer annual dividends that exceed their price per share.
- 04/21/2024
|
Medifast's (MED) Transformation on Track Amid Macro Headwinds
- Medifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing difficulties in attracting customers due to the rapidly changing economy and inflation.
- 04/16/2024
|
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
- BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. T.
- 04/15/2024
|
68 Graham Value Stocks, 57 Fit To Buy In March
- Large Cap Value ranking from YCharts identifies stocks with low prices relative to their assets and profits. Ben Graham Formula strategy selects stable stocks with strong earnings and dividends based on Graham's book "The Intelligent Investor". 57 out of 68 All-Star-Value Dividend stocks offer annual dividends exceeding their price per share.
- 03/18/2024
|
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
- Medifast (MED) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 03/18/2024
|
FSTA: Consumer Staples Sector Dashboard For March
- FSTA: Consumer Staples Sector Dashboard For March
- 03/15/2024
|
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
- Medifast (MED) is foraying into medically supported weight management and sports nutrition segments. However, it continues to encounter difficulties in attracting customers.
- 03/13/2024
|
Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gains
- One tool that bargain hunters can utilize to identify beaten up stocks to buy after significant declines is the relative strength index ( RSI ). The RSI signals when a stock's downward momentum may be exhausted, indicating that a correction could provide upside potential.
- 03/07/2024
|
Medifast Is Getting Attractive
- Medifast Is Getting Attractive
- 03/07/2024
|
Want $10,000 in Passive Income? Invest $2,000 in Each of These Dividend Stocks
- No Commission Fees, No Minimums, No Velvet Ropes.
- 03/01/2024
|
Don't Get Near These 10%+ Dividend Yield Stocks
- URGENT – New Seats Available (sponsored) Top financial advisors are now accepting new clients for 2024!
- 02/28/2024
|
Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
- Medifast's (MED) Q4 results reflect the impacts of poor customer acquisition. However, it is showing resilience, banking on its strategic focus on medically supported weight loss, indicating potential for growth.
- 02/21/2024
|
Medifast, Inc. (MED) Q4 2023 Earnings Call Transcript
- Medifast, Inc. (MED) Q4 2023 Earnings Call Transcript
- 02/20/2024
|
Medifast (MED) Q4 Earnings and Revenues Surpass Estimates
- Medifast (MED) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $3.70 per share a year ago.
- 02/20/2024
|
February's 5 Dividend Growth Stocks With 4.75%+ Yields
- Every month we look at companies that are delivering not only a solid dividend yield but also showing a trend of growing dividends. Companies that can consistently deliver dividend growth due to rising earnings can generate long-term wealth. February 2024's dividend screening article gives us a look at some familiar names but two new names we haven't discussed before.
- 02/17/2024
|
Medifast (MED) Q4 Earnings Coming Up: What Should You Know?
- Medifast's (MED) fourth-quarter results are likely to reflect the impacts of macroeconomic challenges like inflation, while key growth initiatives like innovation bode well.
- 02/16/2024
|
5 Stocks You Have Never Heard of Pay Massive Dividends
- We decided to screen our 24/7 Wall St. dividend research database for companies that pay gigantic dividends that investors have likely never heard of.
- 02/03/2024
|
Medifast's (MED) Holistic Health Solution, Innovation Bode Well
- Medifast's (MED) focus on combining lifestyle coaching with innovative health solutions and targeting diverse markets bode well amid challenges in customer acquisition and high costs.
- 12/26/2023
|
December's 5 Dividend Growth Stocks With 5.10%+ Yields
- Dividend growth stocks can provide reliable cash flows and long-term wealth to income investors. In this monthly publication, we screen dividend stocks based on safety, growth, and consistency, which are important for income investors. The five dividend stocks we are touching on today are Altria, Philip Morris International, Manulife Financial Corp., LyondellBasell Industries N.V., and NETSTREIT Corp.
- 12/19/2023
|
LifeMD expands telehealth GLP-1weight-loss service with Medifast
- LifeMD Inc. NASDAQ: LFMD is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing with no health insurance required.
- 12/19/2023
|
7 Dividend Stocks I Wouldn't Touch With a 10-Foot Pole
- As the markets soar higher following the Federal Reserve's latest decision on interest rates, now may be a great time to jettison any dividend stocks to sell from your portfolio. While stocks overall could continue to perform strongly, company-specific factors can result in poor or even negative returns with many high-yield but low-quality dividend plays.
- 12/18/2023
|
Potential 300% Upside: Uncovering Medifast's Investment Opportunity
- High returns on capital typically generate substantial value for long-term investors over extended periods. Businesses yielding high returns often command premium valuations in the market.
- 12/15/2023
|
Medifast (MED) Collaborates With LifeMD, Discontinues Dividend
- Medifast (MED) penetrates the medically supported weight loss market via a collaboration with LifeMD, Inc. (LFMD). The company discontinues quarterly cash dividends.
- 12/14/2023
|
LifeMD: Medifast Partnership Further Validates Weight Management Program
- Medifast partners with LifeMD to offer virtual weight management program with access to GLP-1 drugs. Medifast invests $20 million in LifeMD, with $10 million represented by common stock purchase. Survey shows over 40% of people with BMI greater than 27 are interested in prescription weight loss medication.
- 12/13/2023
|
LifeMD shares rise on Medifast deal for new GLP supported weight loss programmes
- LifeMD Inc (NASDAQ:LFMD) stock traded higher in Wednesday's early trade, up 11% to $8.99, as the health company announced an agreement with Medifast Inc (NYSE:MED), which sees the new partners working to develop a clinically supported weight management program, featuring GLP-1 medications. GLP-1 (glucagon-like peptide 1) based drugs – which include Novo Nordisk (NYSE:NVO)'s Ozempic -have quickly been adopted as something of a ‘blockbuster' for obesity and weight loss treatments, among an emerging list of other ailments.
- 12/13/2023
|
LifeMD Stock Pops on Medifast Agreement. It's All About Weight-Loss Drugs.
- The companies are teaming up to offer a ‘transformative weight management solution.'
- 12/13/2023
|
LifeMD's stock soars 9.5% on news company is teaming up with Medifast to create weight-management program that includes GLP-1 drugs
- LifeMD Inc.'s stock LFMD, +1.76% soared 9% early Wednesday, after the virtual primary care provider said it's teaming up with Medifast Inc. MED, +1.03%, a wellness company known for its habit-based and coach-guided lifestyle service Optavia, to create a clinically supported weight management program that will include the new class of weight-loss drugs called GLP-1. The drugs developed by Eli Lilly & Co. LLY, +0.12% and Denmark's Novo Nordisk NVO, -0.46% NOVO.B, +1.18% are named after a gut hormone that they mimic to control blood sugar have become highly popular and have even suffered shortages in the past year.
- 12/13/2023
|
7 Doomed Dividend Stocks to Sell in December
- As 2023 comes to a close, now may be a great time to figure out which stocks to sell. If you are an income-focused investor, this may entail figuring out the top dividend stocks to sell.
- 11/27/2023
|
Medifast (MED) Poised on OPTAVIA ACTIVE Line Amid Cost Woes
- Medifast (MED) is proactively positioning itself to tap into the increasing demand for weight loss medications, showcasing a commitment to staying in touch with market trends.
- 11/24/2023
|
November's 5 Dividend Growth Stocks With 5.57%+ Yields
- Dividend growth stocks often provide reliable cash flows and long-term wealth for income investors. Screening dividend stocks based on safety, growth, and consistency can be beneficial to find new opportunities important for investors. In this month's article, we highlight these five dividend stocks: Medifast, Realty Income, ONEOK, VICI Properties, and Cogent Communications Holdings.
- 11/19/2023
|
Medifast (MED) Q3 Earnings Top Estimates, Revenues Decline Y/Y
- Medifast's (MED) Q3 results reflect challenges in customer acquisition. However, cost-reduction efforts and efficiency improvements as part of the "Fuel for the Future" plan bode well.
- 11/07/2023
|
Medifast, Inc. (MED) Q3 2023 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Steven Zenker - Vice President of Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Linda Bolton Weiser - D.A. Davidson Jim Salera - Stephens Inc. Doug Lane - Water Tower Research Operator Greetings.
- 11/06/2023
|
Medifast (MED) Queues for Q3 Earnings: What Awaits the Stock?
- Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition amid a challenging landscape. However, a focus on growth plans bodes well.
- 11/02/2023
|
New Strong Sell Stocks for October 12th
- BGS, MS and MED have been added to the Zacks Rank #5 (Strong Sell) List on October 12, 2023.
- 10/12/2023
|
Are These Consumer Staples Too Cheap for Investors To Ignore?
- Consumer staples NYSEARCA: XLP stocks are down 6.5% from their July highs and more than 10% from the 2022 peaks and may move lower. The caveat is that the sector is trading near the bottom of a range, above critical support, and there are signs of bullish activity in the market.
- 09/20/2023
|
Medifast (MED) Gains on OPTAVIA Lifestyle Solution Strength
- Medifast's (MED) OPTAVIA program is a robust and adaptable solution focused on health and wellness. This holistic approach positions it for sustained long-term growth.
- 09/11/2023
|
Why Is Medifast (MED) Down 7.4% Since Last Earnings Report?
- Medifast (MED) reported earnings 30 days ago. What's next for the stock?
- 09/06/2023
|
Want $500 in Passive Income? 2 High-Dividend Stocks to Snap Up
- British American Tobacco and Medifast each could have solid growth ahead. Both companies' payouts appear to be viable moving forward.
- 08/21/2023
|
August's 5 Dividend Growth Stocks With 5.74%+ Yields
- U.S. credit rating cut by Fitch, inflation trending down and the Fed raising interest rates by another 25 basis points have been the headlines since our last month's article. That being said, life and the search for attractive dividend growth stocks goes on. This month we have four familiar names and one new name that I believe is worth giving a deeper look to, despite its relatively short dividend history.
- 08/18/2023
|
Medifast's (MED) Q2 Earnings Top Estimates, Sales Decline Y/Y
- Medifast's (MED) second-quarter 2023 results reflect lower sales and earnings on reduced Coach productivity and cost inflation.
- 08/08/2023
|
Medifast (MED) Q2 Earnings and Revenues Surpass Estimates
- Medifast (MED) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $3.87 per share a year ago.
- 08/07/2023
|
Medifast, Inc. (MED) Q2 2023 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Steve Zenker - VP of IR Dan Chard - Chairman and CEO Jim Maloney - CFO Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, and welcome to the Medifast Second Quarter 2023 Earnings Conference Call.
- 08/07/2023
|
Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs
- Medifast has seen a significant decline in its stock price and market cap in the past 2 years, reflecting investors' pessimism towards the company. The stock's underperformance may be attributed to inflationary pressures and concerns over new weight loss drugs from pharmaceutical giants Novo Nordisk and Eli Lilly. Concerns over weight loss drugs are overblown and the drugs could in fact be complementary to MED's offering.
- 08/04/2023
|
In The Murky MLM Space, Medifast Might Actually Hold Some Promise
- Medifast, a health and wellness company, has seen its stock price decline by 76% since 2021, despite its Optavia platform helping over 2 million customers with weight loss. The company's earning power value (EPV) and adjusted asset value (AV) suggest the stock is undervalued, with potential for significant returns for value-oriented investors. However, risks include competitive entry, potential malinvestment, MLM regulations and prejudice, and health and sustainability concerns around Medifast's products.
- 07/21/2023
|
7 Small-Cap Stocks Signaling a Sizeable Breakout
- Small-cap breakout stocks offer plenty of robust upside opportunities, but only for the patient and the adventurous. As with practically anything in life, the greater the reward, the higher the risk.
- 07/13/2023
|
New Strong Sell Stocks for June 26th
- ARCH, CSUAY and MED have been added to the Zacks Rank #5 (Strong Sell) List on June 26, 2023.
- 06/26/2023
|
June's 5 Dividend Growth Stocks With 5.93%+ Yields
- Dividend growth stocks can provide growing wealth over time to income investors and potentially promote share price appreciation. The article explores five dividend growth stocks for June: OneMain Holdings, Enbridge, Alpine Income Property Trust, TC Energy Corp, and Cogent Communications Holdings Inc. These stocks were screened based on dividend safety, dividend growth, and dividend consistency, with more due diligence needed before making an investment decision.
- 06/16/2023
|
Medifast: A Revamp Is Necessary, An Embrace Of GLP-1s Can Help
- I view Medifast's traditional business model at increasing risk from the growing popularity of GLP-1-based drugs. Recent M&A activity within the industry provides an indication of the premium investors are willing to pay for those who embrace change. Medifast is currently deploying positive cash flow dollars to the maintenance of an over 8% yielding dividend as well as to share repurchases.
- 06/14/2023
|
Medifast: A High Dividend Yield and Cheap Valuation
- Medifast ( MED , Financial) is a mission-driven company supporting health and well-being, helping its customers transform their lives by providing healthy living products and programs. The company has developed the OPTAVIA brand that offers healthy products and support from experts in science, health and wellness so that customers achieve a transformation in their lives focusing on healthy habits over time.
- 06/14/2023
|
7 Safe High-Yield Dividend Stocks to Buy in June 2023
- In arguably a vast majority of cases, the concept of top safe high-yield dividend stocks represents an oxymoron. Stated differently, if you want robust passive income, you usually must concede your preferences for reliability and sustainability.
- 05/31/2023
|
Medifast Holds Value During Headwinds
- Medifast is a leader in the weight loss industry with a growing customer base. However, Medifast's stock price has gradually declined in 2023.
- 05/28/2023
|
The Dividend Collectuh's 18 Stock Tim Duncan Portfolio
- Invest in high-quality stocks for the long term/mostly investment grade companies. The goal of this portfolio is to collect weekly dividend checks that cover my monthly expenses in retirement.
- 05/23/2023
|
May's 5 Dividend Growth Stocks With 6.08%+ Yields
- May started off on a bit of a sour note, with the broader indexes giving up some of their gains. Declining prices have helped push up dividend yields across the board as share prices fall.
- 05/18/2023
|
Medifast: Strong Earnings But Guidance Disappoints
- Medifast's Q1 2023 EPS of $3.67 beats by $1.27 and revenue of $349M beats analysts' expectations by $29.5M. For Q2 2023, the company expects a ~25% decline in revenue and a ~50% decline in EPS.
- 05/12/2023
|
Medifast's (MED) Q1 Earnings Top Estimates, Sales Decline Y/Y
- Medifast's (MED) first-quarter 2023 results reflect lower sales on reduced Coach productivity and cost inflation. While earnings increase year over year.
- 05/02/2023
|
Medifast, Inc. (MED) Q1 2023 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Steve Zenker - Vice President of Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, and welcome to the Medifast First Quarter 2023 Earnings Conference Call.
- 05/01/2023
|
Factors to Consider Ahead of Medifast's (MED) Q1 Earnings
- Medifast's (MED) first-quarter performance is likely to reflect the adverse impacts of macroeconomic volatility and increased inflation.
- 04/26/2023
|
April's 5 Dividend Growth Stocks With 6.30%+ Yields
- April's 5 Dividend Growth Stocks With 6.30%+ Yields
- 04/18/2023
|
Medifast: Looking Attractively Valued Even Amidst Declining Fundamentals
- Medifast stock was truly exceptional, as it embodied the desirable traits of value, growth, and dividend stocks all in one. However, latest quarterly earnings were down around 10% YoY.
- 04/12/2023
|
Dividend Growth Investing Like Peter Lynch
- Although Peter Lynch wasn't explicitly a dividend growth investor, his principles and advice are highly applicable to a dividend growth strategy. Certain categories and sectors of stocks work better for dividend growth investors than others.
- 04/07/2023
|
Medifast: A High Yield But Low Portfolio Size Hold For Me
- The latest dividend yields over 6% on its market price. The latest dividend payout is less than 50% of its latest quarter earnings.
- 04/03/2023
|
Medifast: An Attractive Dividend But Operating Results Need Further Improvement
- Medifast operates in the health and wellness industry and is the owner of the OPTAVIA brand, a popular weight loss and diet program. The company generates its sales through a large network of independent coaches who work at arms-length with its customer base.
- 03/22/2023
|
March's 5 Dividend Growth Stocks With 5.73%+ Yields
- After a strong start to the year, February pulled us back down to reality. Asset prices have again dropped due to expectations of higher interest rates for longer.
- 03/17/2023
|
Medifast (MED) Stock Down Despite Q4 Earnings, Sales Beat
- Medifast's (MED) fourth-quarter 2022 results reflect reduced Coach productivity and cost inflation. While earnings increase year over year, revenues dip
- 02/22/2023
|
Medifast, Inc. (MED) Q4 2022 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR, Inc. Dan Chard - Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Linda Bolton Weiser - D. A. Davidson & Co. Operator Good afternoon, and welcome to the Medifast Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.
- 02/21/2023
|
Medifast (MED) Tops Q4 Earnings and Revenue Estimates
- Medifast (MED) delivered earnings and revenue surprises of 69.72% and 9.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/21/2023
|
February's 5 Dividend Growth Stocks With 5.43%+ Yields
- The market has started off 2023 with a strong run across most of the major indexes. With an uncertain future, dividend growth stocks can be one place to consider investing in to generate returns.
- 02/17/2023
|
Medifast (MED) Readies for Q4 Earnings: Everything to Note
- Medifast's (MED) fourth-quarter results are likely to reflect the adverse impacts of increased cost inflation, while strength in the OPTAVIA lifestyle solution and coaching support system bodes well.
- 02/16/2023
|
7 Undervalued Reddit Stocks to Buy Now
- Despite the frenzy over meme stocks dying down a while ago, plenty of undervalued Reddit stocks are available for investors to pick up. Reddit's social media platform hosts one of the largest communities of traders.
- 12/20/2022
|
7 Ridiculously Cheap Stocks Yielding 5% in 2023
- In 2023, stock market uncertainties will worsen, rewarding investors who seek cheap dividend stocks. The bigger their discount to their fair value, the more margin of safety the company offers.
- 12/20/2022
|
Medifast Stock Shows Promise At Current Valuation
- Medifast is a health and wellness company that has fallen more than 40% YTD and is more than 60% off its 5 year average P/E and EV/EBITDA. The stock's decline is an overreaction to fears that growth will slow down in FY2023 amid inflation and a possible recession that could affect sales of its weight loss meals.
- 12/09/2022
|
Got $1,000? 2 Ultra High-Yield Dividend Stocks to Get Your Hands On
- These two stocks offer whopping dividend yields ranging from 5.5% to 8%.
- 12/03/2022
|
Cash (Flow) Is King: 2 Cash-Rich High Yielders To Weather The Storm
- Hedge fund manager and billionaire Ray Dalio recently changed his view that "cash is trash." But if investors had taken Dalio's advice before, they would have no cash with which to invest in his new recommendation.
- 11/16/2022
|
Buy This Undervalued Stock Before Everyone Else Does
- The average analyst 12-month price target of the nutrition and weight loss stock works out to a mind-boggling 171% upside.
- 11/06/2022
|
Medifast: This High-Yield Blue Chip Dividend Stock Is A Strong Buy
- Medifast's adjusted diluted EPS payout ratio will expand from just 38.8% in 2021 to a still manageable 51.6% in 2022. The company is admirably navigating a difficult environment, with revenue up 9.8% year to date and adjusted diluted EPS down 1.5% over the year-ago period.
- 11/06/2022
|
Medifast, Inc. (MED) Q3 2022 Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Reed Anderson - ICR Daniel Chard - Executive Chairman & CEO James Maloney - CFO Conference Call Participants Christina Xue - D.A. Davidson Operator Good day, and welcome to the Medifast Third Quarter 2022 Earnings Conference Call.
- 11/03/2022
|
Medifast's (MED) Q3 Earnings Upcoming: Things Worth Noting
- Medifast's (MED) third-quarter 2022 results are likely to reflect cost-related challenges, whereas strength in the OPTAVIA lifestyle solution and coaching support system bodes well.
- 11/01/2022
|
These High-Yield Dividend Stocks Are Growing at Blazing Speeds
- These two stocks each yield more than 5%.
- 10/14/2022
|
2 High-Yield Blue-Chip Bargains That Could Change Your Life
- The Fed is working very hard to get Wall Street to believe they are not going to pivot and stocks are gradually getting the message. The short-term pain in the market is likely to continue for a few more weeks or even several months.
- 10/11/2022
|
My Top 10 Dividend Payers For September
- Dividends are an important source of income for investors of all types but especially those that rely on their investments in retirement. My ideal dividend payer accomplishes four goals: maximize total return, deliver a meaningful yield, experience strong growth, and provide a margin of safety.
- 09/19/2022
|
7 Dividend Stocks to Buy and Hold Forever
- If you're looking for dividend stocks to buy and hold forever, a good place to start is companies that have done an excellent job increasing their dividends and are expected to keep doing so in the future. While the first place to look for such names should logically be a list of S&P 500 Dividend Aristocrats, I widened the search to the S&P 1500.
- 09/14/2022
|
Losing Weight Is Losing Ground in the Stock Market
- Weight-loss and nutrition companies have lost half or more of their value in the past year despite expectations of a postpandemic boom.
- 09/12/2022
|
Medifast: Would Chuck Akre Approve?
- It is a consistently profitable growth company that was recognized by Fortune and Forbes several times. Yet, the stock has crashed over 64% since it peaked on 1st May 2021, falling from $332.25 to $119.05 as of 2 September 2022.
- 09/12/2022
|
Medifast (MED) Down More Than 20% in 3 Months on Cost Woes
- Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.
- 08/31/2022
|
Medifast: Let's Dive Into Its Q2 Earnings And Assess The Bad And The Good
- Medifast's stock plummeted 16% after reporting Q2 earnings. Both earnings and revenue beat analysts' consensus but guidance was cut significantly.
- 08/21/2022
|
Medifast (MED) Q2 Earnings Top Estimates, Guidance Lowered
- Medifast's (MED) second-quarter 2022 results reflect increased active earning OPTAVIA Coaches and elevated costs. Management cuts guidance for 2022 due to inflation.
- 08/04/2022
|
Medifast, Inc. (MED) CEO Dan Chard on Q2 2022 Results - Earnings Call Transcript
- Medifast, Inc. (NYSE:MED ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Reed Anderson - ICR, Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Operator Good afternoon. And welcome to Medifast Second Quarter 2022 Earnings Conference Call.
- 08/03/2022
|
Explore DuPont Analysis & Pick 5 Top Stocks
- Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
- 08/01/2022
|
Dive Into DuPont Analysis & Pick 5 Top Stocks
- Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
- 07/29/2022
|
Medifast (MED) is a Top Dividend Stock Right Now: Should You Buy?
- Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes?
- 07/28/2022
|
Dive Into DuPont Analysis & Pick 5 Top Stocks
- Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
- 07/18/2022
|
This is Why Medifast (MED) is a Great Dividend Stock
- Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes?
- 07/12/2022
|
Medifast: Generating Well-Being For Both Customers And Shareholders
- MED is one of the few stocks which combines good characteristics of value, growth, and dividend stocks. Measured at its historic multiples and the multiples of the sector, the MED stock is undervalued right now.
- 06/29/2022
|
Why Medifast (MED) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 06/28/2022
|
Medifast And Its Real Value
- Medifast, Inc. is a fast-growing company that continues to generate increasing profits and excellent returns for investors. In addition to solid growth, the company offers a hefty dividend.
- 06/24/2022
|
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 06/24/2022
|
Medifast (MED) Benefits From Solid OPTAVIA Lifestyle Solution
- Medifast (MED) has been gaining from its OPTAVIA lifestyle solution and coaching support system due to consumers' rising inclination toward health.
- 06/21/2022
|
14 June High-Yield And High-Rising Dividend Dogs Ready To Buy
- June 2022, The AAII Journal listed two sets of stocks sorted as: High-Yielding Dividend Payers, and Biggest Rising Dividend Payers. Those two articles revealed 40 dividend-paying-equities. The American Association of Individual Investors (AAII) is an independent non-profit corporation assisting individual investors through programs of education, information, and research.
- 06/16/2022
|
Is MEDIFAST (MED) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/15/2022
|
5 Top-Ranked Stocks Empowered by DuPont Analysis
- Have more faith in DuPont analysis than simple ROE calculation and bet on these five stocks.
- 06/15/2022
|
Can Medifast rise above the $190 resistance?
- Medifast Inc (NYSE:MED) is a consumer defensive value stock. Investors would consider buying and holding for the bear market.
- 06/13/2022
|
10 Best Dividend Stocks to Buy Now
- These top dividend stocks are attractive at these levels and lower, and they add excellent diversity to a long-term investing portfolio.
- 06/11/2022
|
3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)
- Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 06/08/2022
|
Should Value Investors Buy MEDIFAST (MED) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/30/2022
|
Medifast: Growth And Value At A Reasonable Price
- Positive Q1 results that confirm our thesis. Unique business proposition, self-financed with a virtuous circle.
- 05/17/2022
|
5 High Earnings Yield Value Picks Amid Market Jitters
- Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.
- 05/16/2022
|
Are Investors Undervaluing MEDIFAST (MED) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/13/2022
|
3 Reasons Why Medifast (MED) Is a Great Growth Stock
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 05/10/2022
|
Medifast (MED) Tops Q1 Earnings & Sales Estimates, Raises View
- Medifast's (MED) first-quarter 2022 results reflect increased earnings and revenues owing to continued strength in OPTAVIA. Management raises sales and earnings view for 2022.
- 05/04/2022
|
Medifast, Inc.'s (MED) CEO Dan Chard on Q1 2022 Results - Earnings Call Transcript
- Gaia, Inc. (GAIA) Q1 2022 Earnings Conference Call May 2, 2022 4:30 PM ET Company Participants Dan Chard - Chairman and CEO Jim Maloney - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Linda Bolton Weiser - D.A. Davidson Doug Lane - Lane Research Operator Good afternoon.
- 05/02/2022
|
Medifast (MED) Q1 Earnings and Revenues Top Estimates
- Medifast (MED) delivered earnings and revenue surprises of 0.84% and 0.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/02/2022
|
2 Ugly Ducklings To Consider For Your Dividend Growth Portfolio
- Primerica and Medifast are two companies that can be punished because of unusual business models. Both Primerica and Medifast have excellent fundamentals and have shown the ability to grow the dividend rapidly over time.
- 04/29/2022
|
Things to Note as Medifast (MED) Lines Up for Q1 Earnings
- Medifast's (MED) first-quarter results are likely to reflect gains from the OPTAVIA lifestyle solution and coaching support system, whereas high costs are a concern.
- 04/29/2022
|
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2022
- BALTIMORE , April 18, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA ® , will announce financial results for the first quarter ended March 31, 2022 on Monday, May 2, 2022, after market close. The Company will host a conference call to discuss the results with additional comments and details.
- 04/18/2022
|
Medifast, Inc: Winning Profits In The Business Of Losing Weight
- Medifast operates with a high growth business model with recurring revenue.
- 04/12/2022
|
My Top 10 Dividend Payers For April
- Dividends are a powerful tool that investors should employ to achieve a balance of total return and low volatility.
- 04/06/2022
|
Medifast (MED) Troubled by High SG&A Costs, Gross Margin Woes
- Medifast (MED) has been seeing high SG&A expenses for a while now, mainly due to higher OPTAVIA commission costs. The company's gross margin has also been under pressure.
- 04/06/2022
|
Medifast: A Growth Company For Value Investors
- By the end of 2021, Medifast's revenue grew by 63.2%, and the number of coaches grew by 35.3% year-over-year to 59.8 thousand.
- 03/07/2022
|
Medifast's (MED) CEO Dan Chard on Q4 2021 Results - Earnings Call Transcript
- Medifast's (MED) CEO Dan Chard on Q4 2021 Results - Earnings Call Transcript
- 02/23/2022
|
Medifast (MED) Surpasses Q4 Earnings and Revenue Estimates
- Medifast (MED) delivered earnings and revenue surprises of 8.99% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/23/2022
|
Medifast (MED) Queued for Q4 Earnings: Key Things to Note
- Medifast's (MED) fourth-quarter 2021 results are likely to reflect strength in the OPTAVIA lifestyle solution and coaching support system and the benefits from growth-related initiatives.
- 02/18/2022
|
Land on 5 Winning Stocks With the Overlooked Rising P/E Trick
- Stocks with rising P/E often proves to be an intriguing investing idea.
- 02/15/2022
|
Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
- BALTIMORE, Feb. 11, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2021 on Wednesday, February 23, 2022, after market close. The Company will host a conference call to discuss the results with additional comments and details.
- 02/11/2022
|
3 Reasons Growth Investors Will Love Medifast (MED)
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 02/07/2022
|
Bank on Rising P/E Investing With These 5 Top-Ranked Stocks
- Want to try a different approach? Tap five stocks with increasing P/E ratios such as MEDIFAST (MED), JAKKS Pacific (JAKK), Asbury Automotive Group (ABG), Zymeworks (ZYME) and Polaris (PII).
- 01/31/2022
|
Medifast (MED) Looks Great on OPTAVIA, Strategic Investments
- Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system, as well as efficient technological investments.
- 01/26/2022
|
Medifast: A Unique Marketing Model That Welcomes The Well-Being Of All Stakeholders
- 9m'21 revenues growing by 70% compared to previous year.
- 01/19/2022
|
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- 01/13/2022
|
What Makes Medifast (MED) a New Buy Stock
- Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 01/13/2022
|
Medifast, Inc. to Present at the 2022 ICR Conference
- BALTIMORE, Dec. 29, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer, will present at the 2022 ICR Conference on Tuesday, January 11, 2022. The presentation is scheduled to begin at 2:30 p.m.
- 12/29/2021
|
Medifast (MED) Gains on OPTAVIA Strength, SG&A Costs Rise
- Medifast (MED) has been gaining on strength of its OPTAVIA lifestyle solution and coaching support system, which was a major driver in the third quarter.
- 12/24/2021
|
Medifast: A Unique Opportunity For Both Growth And Value Investors
- The company's management targets sustainable 15% growth in revenues and operating income over the long term.
- 12/07/2021
|
Tracking Warren Buffett's Future Dividend Picks: 21 From AAII's Hagstrom Screen
- The American Association of Individual Investors (AAII) publishes monthly tips for members on-line. Their November Journal featured these thirty Buffett-worthy candidates by one of Buffett's closest followers, Robert Hagstrom.
- 11/21/2021
|
4 Stocks That Look Like Potential Bargains
- As of Nov. 18, the following stocks look underestimated by the market, as their price-earnings ratios without non-recurring items (NRI) trade below 20 while their price-earnings to growth (PEG) ratios trade near or below 1.
- 11/19/2021
|
Should Value Investors Pick Medifast (MED) Stock Now?
- Is Medifast (MED) a great pick from the value investor's perspective right now? Read on to know more.
- 11/16/2021
|
3 Blue-Chips That Could Triple In The Next 5 Years
- The red hot market continues, with stocks rising for eight straight days, and five straight weeks (this could be the sixth). The S&P 500 is now 30% overvalued.
- 11/11/2021
|
Can The Federal Trade Commission Drain A Swamp?
- Can The Federal Trade Commission Drain A Swamp?
- 11/06/2021
|
Medifast (MED) Raises View on Q3 Earnings & Revenue Beat
- Medifast's (MED) third-quarter 2021 results reflect stellar earnings and revenues, courtesy of continued strength in OPTAVIA. Management raises earnings per share and revenue guidance for 2021.
- 11/05/2021
|
Medifast, Inc. (MED) CEO Dan Chard on Q3 2021 Results - Earnings Call Transcript
- Medifast, Inc. (MED) CEO Dan Chard on Q3 2021 Results - Earnings Call Transcript
- 11/05/2021
|
Medifast (MED) Q3 Earnings and Revenues Surpass Estimates
- Medifast (MED) delivered earnings and revenue surprises of 21.92% and 1.40%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
10 Dividend Growth Stocks For October 2021
- This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to obtain quality scores, sort them in descending order, and break ties with additional metrics.
- 10/17/2021
|
Medifast and its OPTAVIA Community Promote Healthy Habits around the World with Third Annual Philanthropic Event
- BALTIMORE, Oct. 11, 2021 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one the fastest-growing health and wellness communities, OPTAVIA ®, hosted its third annual Healthy Habits For All® Week Monday, Sept. 20 through Sunday, Sept.
- 10/11/2021
|
Medifast: A 5-Year Dividend CAGR Of 48%, But No Moat
- MED is one of the most impressive dividend growers in the market. Since 2017 the company grew its top and bottom line by double-digit growth and is expected to continue to do so in the next years.
- 10/09/2021
|
Medifast: Perfect For Dividend-Growth Investors
- Medifast: Perfect For Dividend-Growth Investors
- 10/04/2021
|
7 Consumer Stocks That Are Also Serving Up Delicious Dividends
- This collection of consumer stocks combines growth potential with a solid dividend track record. Here's why each should be on your radar.
- 09/29/2021
|
Medifast (MED) Worth Relishing on OPTAVIA Strength, Growth Plans
- Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system as well as focus on capacity expansion and technological advancements.
- 09/21/2021
|
81% of U.S. Adults Value Support from Someone with Similar Experiences when Creating Healthy Habits
- BALTIMORE, Sept. 15, 2021 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one the fastest-growing health and wellness communities, OPTAVIA®, released findings from back-to-back surveys designed to explore whether people seek support in achieving their health and wellness goals.
- 09/15/2021
|
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 09/14/2021
|
Medifast, Inc. Announces Quarterly Dividend
- BALTIMORE, Sept. 9, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA® , announced today that its Board of Directors has declared a $1.42 quarterly cash dividend to its stockholders.
- 09/09/2021
|
3 of the Best Efficient Stocks to Boost Your Portfolio
- Delta Apparel (DLA), MEDIFAST (MED) & Service Corporation International (SCI) are at present the three top efficient stocks that need to be added to your portfolio.
- 09/03/2021
|
Medifast (MED) Looks Tempting: Rallies More Than 35% in a Year
- Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system as well as strategic growth endeavors like technological advancements.
- 09/02/2021
|
3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 08/27/2021
|
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 08/20/2021
|
Buy 5 Top-Ranked Efficient Stocks for a Solid Portfolio
- MEDIFAST (MED), Smith & Wesson Brands (SWBI), Encore Wire (WIRE), Cavco Industries (CVCO) & Apple (AAPL) at present flaunt solid efficiency levels and are thus believed to provide stellar returns in the near future.
- 08/17/2021
|
10 Dividend Growth Stocks For August 2021
- This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration.
- 08/15/2021
|
Medifast (MED) Loses 13.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- The heavy selling pressure might have exhausted for Medifast (MED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 08/13/2021
|
OPTAVIA® App Launches, One of First Innovations Coming Out of New Office Focused on Digital Experience
- BALTIMORE, Aug. 11, 2021 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, has announced the launch of the OPTAVIA app, a new digital tool for Clients that includes Lean & Green recipes and access to order history, auto-ship details, account information and more. Over the past several years, Medifast has invested in its digital infrastructure, with the goal of allowing Coaches to more efficiently run their businesses and better support Clients on their holistic health journeys.
- 08/11/2021
|
5 Top Rated Stocks to Pick With Solid Net Profit Margins
- Let's take a look at the five top ranked stocks with stellar net profit margins for a winning portfolio.
- 08/10/2021
|
5 Top-Performing Liquid Stocks to Snap Up for Higher Returns
- Here are five top-ranked liquid stocks, Magnolia Oil & Gas (MGY), Medifast (MED), Textron (TXT), ConocoPhillips (COP) and Steven Madden (SHOO), which investors can consider for attractive returns.
- 08/06/2021
|
Medifast (MED) Surpasses Q2 Earnings & Revenue Estimates
- Strength in independent OPTAVIA Coaches along with gross margin expansion and lower SG&A expense rate aids Medifast (MED) in Q2.
- 08/05/2021
|
Medifast, Inc. (MED) CEO Dan Chard on Q2 2021 Results - Earnings Call Transcript
- Medifast, Inc. (MED) CEO Dan Chard on Q2 2021 Results - Earnings Call Transcript
- 08/04/2021
|
Medifast (MED) Surpasses Q2 Earnings and Revenue Estimates
- Medifast (MED) delivered earnings and revenue surprises of 20.00% and 7.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2021
|
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- 08/02/2021
|
OPTAVIA® Community Reunites as Global Convention Returns with Hybrid Format
- BALTIMORE, Aug. 2, 2021 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA ®, held its annual OPTAVIA Convention last week from July 29–Aug. 1 in a new hybrid format. With an in-person experience held at the Georgia World Congress Center in Atlanta and a livestream component for attendees who chose to participate from home, the global event saw more than 15,000 registrants.
- 08/02/2021
|
Medifast (MED) Queued for Q2 Earnings: Key Things to Note
- Medifast's (MED) second-quarter 2021 results are likely to reflect continued strength in OPTAVIA lifestyle solution and coaching support system.
- 07/30/2021
|
Why Medifast (MED) is a Top Dividend Stock for Your Portfolio
- Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes?
- 07/27/2021
|
Medifast: A Rare Combination Of Growth, Profitability, And A Good Price
- We expect the company to continue to grow revenues due to the favorable market environment, as well as profitability due to a further reduction in the share of SG&A. There is potential for further growth in asset turnover by reducing cash & cash equivalents.
- 07/25/2021
|
Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2021
- BALTIMORE, July 21, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2021 on Wednesday, August 4, 2021, after market close. The Company will host a conference call to discuss the results with additional comments and details.
- 07/21/2021
|
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 07/15/2021
|
4 Profitable Stocks Boasting Amazingly High Net Income Ratio
- Net income ratio gives us the exact profitability level of a company. It reflects the percentage of net income to total sales revenues.
- 07/02/2021
|
Medifast: Strong Growth Driven By Optavia
- Medifast: Strong Growth Driven By Optavia
- 07/01/2021
|
Get Over the Meme Frenzy, Dig Into These 4 Food Stocks Instead
- Food stocks like Darling Ingredients (DAR), Medifast (MED), Hain Celestial (HAIN) and Nomad Foods (NOMD) are great investment options for those looking to bypass the meme craze.
- 07/01/2021
|
4 Top-Rated Efficient Stocks to Enrich Your Portfolio
- MEDIFAST (MED), Vista Outdoor (VSTO), International Paper (IP) & Hess (HES) are the four top-ranked stocks that have a favorable efficiency level and are expected to provide stellar returns.
- 07/01/2021
|
Looking for a Growth Stock? 3 Reasons Why Medifast (MED) is a Solid Choice
- Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 06/24/2021
|
5 Top-Ranked Liquid Stocks to Enrich Your Portfolio in 2021
- Here are five top-ranked liquid stocks -- Medifast (MED), Boyd Gaming (BYD), National Vision Holdings (EYE), Gentherm (THRM) and Generac Holdings (GNRC) -- which investors can tap for alluring returns.
- 06/23/2021
|
Medifast (MED) Stock More Than Doubles in a Year: Here's Why
- Medifast (MED) has been benefiting from consumers' increased inclination toward health, along with a solid OPTAVIA coach-based model. These have been helping the company draw new clients.
- 06/21/2021
|
4 Stocks With High Net Income Ratio to Scoop Up
- High net income ratio stocks for the day include Teledyne Technologies (TDY), Medifast, Inc. (MED), PetroChina Company (PTR), and Tilly's, Inc. (TLYS).
- 06/18/2021
|
Medifast (MED) Sees Hammer Chart Pattern: Time to Buy?
- Medifast (MED) has been struggling lately, but the selling pressure may be coming to an end soon
- 06/18/2021
|
Medifast Survey Finds 93% of U.S. Adults Set Health Goals
- BALTIMORE, June 11, 2021 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one the fastest-growing health and wellness communities, OPTAVIA ®, today released findings from a nationally-representative study on consumer health priorities and motivators. In an earlier survey from December 2020 *, the company found 63% of Americans had adopted new, positive health routines amid the pandemic, 96% of whom planned to continue embracing healthy habits in the new year.
- 06/11/2021
|
Why Medifast Stock Jumped 46% in May
- Market-thumping sales growth is holding up through early 2021.
- 06/08/2021
|
Medifast, Inc. Announces Quarterly Dividend
- BALTIMORE, June 3, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA® , announced today that its Board of Directors has declared a $1.42 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.42 per share is payable on August 6, 2021 to stockholders of record as of the close of business on June 22, 2021.
- 06/03/2021
|
Medifast (MED) is on the Move, Here's Why the Trend Could be Sustainable
- If you are looking for stocks that are well positioned to maintain their recent uptrend, Medifast (MED) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
- 06/02/2021
|
5 High-Flying Growth Stocks to Buy Despite Inflation Concern
- We have narrowed down our search to five growth stocks that have popped more than 10% in the past month. These are; MED, TEN, DDS, OLN and PDCE.
- 05/27/2021
|
3 Reasons Growth Investors Will Love Medifast (MED)
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 05/26/2021
|
Can the Rally in Medifast (MED) Shares Continue?
- As of late, it has definitely been a great time to be an investor of Medifast (MED)
- 05/20/2021
|
5 Stocks With Recent Price Strength Amid Inflation Concern
- Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength like GNK, SBLK, TSQ, MED and DLA have a high chance of carrying the momentum forward.
- 05/18/2021
|
What Makes Medifast (MED) a Good Fit for "Trend Investing"
- Medifast (MED) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
- 05/17/2021
|
Boost Your Future Income With These Fast Growing Dividends
- Fast growing dividends may have low initial yields but will grow rapidly over time.
- 05/12/2021
|
4 Must-Buy Efficient Stocks to Enrich Your Portfolio
- Crocs (CROX), MEDIFAST (MED), Golden Entertainment (GDEN) and Herbalife (HLF) are the top companies that at present have favorable efficiency level and thus are expected to provide stellar returns.
- 05/12/2021
|
Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners
- The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
- 05/10/2021
|
5 Mid-Cap Stocks That Reported Solid Q1 Results
- Diversify your portfolio to include some mid-cap stocks.
- 05/06/2021
|
Medifast (MED) Moves 12.1% Higher: Will This Strength Last?
- Medifast (MED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
- 05/06/2021
|
Medifast tops Q1 earnings and revenue estimates
- Dan Chard, Medifast Chairman & CEO joins the Yahoo Finance Live panel to discuss their Q1 earnings results. Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 05/05/2021
|
3 Reasons Why Medifast (MED) Is a Great Growth Stock
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 05/05/2021
|
Medifast (MED) Stock Gains on Q1 Earnings & Revenue Beat
- Medifast's (MED) first-quarter 2021 results reflect robust earnings and sales growth. The company continued to gain on solid OPTAVIA performance, courtesy of a rise in active earning coaches.
- 05/05/2021
|
Medifast (MED) Tops Q1 Earnings and Revenue Estimates
- Medifast (MED) delivered earnings and revenue surprises of 27.21% and 18.71%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2021
|
Medifast, Inc. (MED) CEO Dan Chard on Q1 2021 Results - Earnings Call Transcript
- Medifast, Inc. (MED) CEO Dan Chard on Q1 2021 Results - Earnings Call Transcript
- 05/04/2021
|
Here's How Medifast (MED) is Placed Ahead of Q1 Earnings
- Strength in the OPTAVIA lifestyle solution and coaching support system have most likely aided Medifast's (MED) first-quarter 2021 performance.
- 04/30/2021
|
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- 04/14/2021
|
Medifast - A Fast Growing Stock For Dividend Investors
- Medifast has grown its revenues and earnings double digits since 2017. The stock performance has been outstanding as the price increased from $18 to $222 in 10 years which results in an annual return of 28.6%.
- 04/05/2021
|
Medifast (MED) Rallies More Than 25% in 6 Months: Here's Why
- Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system, which is well placed given consumers' rising inclination toward health and wellness.
- 04/01/2021
|
Why Is Medifast (MED) Down 11.9% Since Last Earnings Report?
- Medifast (MED) reported earnings 30 days ago. What's next for the stock?
- 03/27/2021
|
Dividend Increases: March 13-19, 2021
- This article series provides a weekly summary of dividend changes. A table with relevant data and key statistics of dividend increases is provided.
- 03/26/2021
|
Medifast-Sponsored Survey Reveals U.S. Adults' Healthy Eating Priorities for 2021
- BALTIMORE, March 24, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA ® , today released survey findings from a consumer study designed to further understand trends around nutritional priorities and challenges. As we mark the one-year anniversary of the pandemic in the U.S., many Americans are putting increased emphasis on the importance of working toward optimal health and wellness with healthy eating being a major component of success.
- 03/24/2021
|
Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why
- Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- 03/23/2021
|
Medifast, Inc. Announces Quarterly Dividend
- BALTIMORE, March 18, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA ® , announced today that its Board of Directors has declared a $1.42 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.42 per share is payable on May 6, 2021 to stockholders of record as of the close of business on March 30, 2021.
- 03/18/2021
|
5 Must-Buy Efficient Stocks to Make Your Portfolio Stand Out
- Crocs (CROX), iRobot (IRBT), Sprouts Farmers Market (SFM), Meridian Bioscience (VIVO) & MEDIFAST (MED) are the top five companies boasting solid efficiency levels at present.
- 03/17/2021
|
3 Reasons Why Medifast (MED) Is a Great Growth Stock
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 03/05/2021
|
Medifast, Inc. (MED) CEO Dan Chard on Q4 2020 Results - Earnings Call Transcript
- Medifast, Inc. (MED) CEO Dan Chard on Q4 2020 Results - Earnings Call Transcript
- 02/25/2021
|
Medifast (MED) Lined Up for Q4 Earnings: Key Things to Note
- Medifast's (MED) fourth-quarter 2020 results are likely to reflect strength in OPTAVIA, thanks to consumers' growing inclination toward health and wellness.
- 02/22/2021
|
E-commerce Drives Grocery Sales in January: 4 Stocks to Buy
- Although retailers have been struggling, grocery stocks like Target Corporation (TGT) and The Hain Celestial Group, Inc. (HAIN) have been benefiting since the coronavirus outbreak.
- 02/19/2021
|
Rotation Continues But Gains Pared On Capitol Protest: Target, Medifast, General Motors In Focus
- Rotation Continues But Gains Pared On Capitol Protest. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 01/06/2021
|
4 Food Stocks Up More Than 50% in 2020 With Room to Grow
- Several food companies are gaining on higher at-home consumption amid the pandemic. Also, focus on innovation and other brand-building efforts has been backing growth for B&G Foods (BGS), Hain Celestial (HAIN), Medifast (MED) and United Natural (UNFI).
- 12/31/2020
|
5 Dividend Stocks to Consider for 2021
- According to the All-in-one Screener, a Premium feature of GuruFocus, five stocks with high financial strength and good dividend yields that have outperformed the Standard & Poor's 500 Index in 2020 are Medifast Inc. (NYSE:MED), Weis Markets Inc. (NYSE:WMK), Nu Skin Enterprises Inc. (NYSE:NUS), Big Lots Inc. (NYSE:BIG) and SpartinNash Co. (NASDAQ:SPTN).
- 12/30/2020
|
5 Stocks With Unstoppable Growth to Buy in 2021
- Investing in stocks which have outpaced the market in 2020, defying the impacts of the COVID-19 outbreak, and have the potential for greater returns in 2021 is advisable.
- 12/30/2020
|
Medifast, Inc. to Present at the 23rd Annual ICR Conference
- BALTIMORE, Dec. 29, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer, will present...
- 12/29/2020
|
Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 12/24/2020
|
Here's Why Medifast (MED) is Likely to Sustain Solid Run in 2021
- Medifast (MED) has been benefiting from strength in OPTAVIA along with a focus on core growth strategies even amid the pandemic.
- 12/24/2020
|
Michael MacDonald to Step Down as Non-Executive Chairman of Medifast's Board of Directors; Chief Executive Officer Dan Chard Named Chairman
- BALTIMORE, Dec. 14, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced that Non- Executive Chairman of the Board, Michael MacDonald, has stepped down from the role. At its regularly...
- 12/14/2020
|
Medifast, Inc. Announces Quarterly Dividend
- BALTIMORE, Dec. 10, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of Directors has declared a $1.13 quarterly cash dividend to its stockholders. The quarterly cash...
- 12/10/2020
|
Top Growth Stocks For December
- Growth names have been at the forefront of this new COVID world, and have kept society not only afloat, but growing and transitioning to this new normal. Nobody knows exactly what the future will hold, but our AI algorithms have identified standout growth stocks via our rating system.
- 12/02/2020
|
Healthy Living Stocks for the Win (NASDAQ: WW) (NYSE: PLNT) (OTC: SBEV) (NYSE: MED)
- Healthy Living Stocks for the Win (NASDAQ: WW) (NYSE: PLNT) (OTC: SBEV) (NYSE: MED)
- 11/11/2020
|
Post-Election Market Outlook: What to Expect
- Where does Louis Navellier see stocks heading when the U.S. presidential election is in the rear-view mirror? Poised to go much higher.
- 11/03/2020
|
Medifast, Inc. (MED) CEO Dan Chard on Q3 2020 Results - Earnings Call Transcript
- Medifast, Inc. (MED) CEO Dan Chard on Q3 2020 Results - Earnings Call Transcript
- 11/02/2020
|
Medifast, Inc. (MED) CEO Dan Chard on Q3 2020 Results - Quick Version Earnings Call Transcript
- Medifast, Inc. (MED) CEO Dan Chard on Q3 2020 Results - Quick Version Earnings Call Transcript
- 11/02/2020
|
Medifast, Inc. Ranks Number Two on FORTUNE's Annual 100 Fastest-Growing Companies List
- BALTIMORE, Nov. 2, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the company behind one of the fastest growing health and wellness communities, OPTAVIA®, which offers Lifelong Transformation, One Healthy Habit at a Time®, today announced it was ranked second on FORTUNE© Magazine's list...
- 11/02/2020
|
Medifast: Dividend Stock With Strong Future Growth Potential
- The large amount of overweight adults in the United States and other regions provides a significant market for Medifast's growth. Medifast has positive revenue and earnings growth momentum that can continue in future years.
- 10/29/2020
|
Dividend Challenger Highlights: Week Of September 13
- A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends.
- 09/12/2020
|
The Sell-Off Accelerates, What To Do Now
- The S&P 500's sell-off accelerates. The best sectors and stocks to consider when it bottoms.
- 09/03/2020
|
You Can Still Buy Industrial And Technology Stocks, But Risk Controls Are Key
|
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 08/19/2020
|
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin
- Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin
- 08/17/2020
|
Medifast Is The One That Got Away (NYSE:MED)
- With a current revenue of nearly $400 million, it is now clear the company will exceed its original revenue guidance.
- 08/10/2020
|
Nisa Investment Advisors LLC Sells 1,400 Shares of Medifast Inc (NYSE:MED)
- Nisa Investment Advisors LLC trimmed its position in shares of Medifast Inc (NYSE:MED) by 28.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,500 shares of the specialty retailer’s stock after selling 1,400 shares during the quarter. Nisa […]
- 08/09/2020
|
I Built A List Of Growing Companies And Medifast (NYSE:MED) Made The Cut
- For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- 08/06/2020
|
Medifast (MED) Q2 Earnings Top Estimates on OPTAVIA Strength
- Medifast's (MED) second-quarter 2020 results reflect solid earnings and sales. Strong OPTAVIA performance, thanks to a substantial rise in active earning coaches, boosted results.
- 08/06/2020
|
Medifast (MED) Beats Q2 Earnings and Revenue Estimates
- Medifast (MED) delivered earnings and revenue surprises of 6.52% and 12.97%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2020
|
Medifast, Inc. Announces Second Quarter 2020 Financial Results
- Medifast (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the second quarter ended June 30, 2020.
- 08/05/2020
|
Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
- Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
- 08/05/2020
|
Top 7 Stocks Set to Beat on Earnings Today After Market
- Seven top-ranked companies are poised to beat on earnings today after the closing bell.
- 08/05/2020
|
The Zacks Analyst Blog Highlights: Reynolds Consumer Products, Ollie's Bargain Outlet, Medifast and Flowers Foods
- The Zacks Analyst Blog Highlights: Reynolds Consumer Products, Ollie's Bargain Outlet, Medifast and Flowers Foods
- 08/04/2020
|
3 Dividend Stocks Killing It This Year (They Are Not Tech Stocks Or Gold)
- The S&P 500 has been lifted by big tech stocks. Gold and gold stocks are also getting lots of market love.
- 08/04/2020
|
What's in the Cards for Medifast (MED) This Earnings Season?
- Strength in OPTAVIA brand is likely to get reflected in Medifast's (MED) second-quarter 2020 performance. However, rising SG&A expenses is a concern.
- 08/03/2020
|
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 08/03/2020
|
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
- The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
- 07/31/2020
|
Miller Value Partners Opportunity Equity 2Q 2020 Letter
- Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term.
- 07/29/2020
|
Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2020
|
OPTAVIA® Hosts New Digital Experience, OPTAVIA Together Live
- Medifast (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, hosted a new, live broadcast event experience, OPTAVIA Together Live, replacing its traditional in-person convention which was cancelled due to the global pandemic. The international event, streamed July 24 –26, attracted more than 50,000 registrants from across the globe. The event offered Coach-led educational sessions and panel discussions about the company's mission to offer the world Lifelong Transformation, One Healthy Habit at a Time®. The presentations generated more than 140,000 views on Facebook, as Coaches hosted watch parties and live events on social media.
- 07/29/2020
|
Does Medifast (MED) Have A Place In Your Dividend Portfolio?
- Miller Value Partners recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 47.02% for the quarter (net of fees), outperforming its benchmark, the S&P 500 Index which returned 20.54% in the same quarter. You should check out Miller Value Partners' top […]
- 07/27/2020
|
The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy
- The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy
- 07/27/2020
|
Rising Risk? Here's What You Can Buy
- Volatility caused by dismal economic data creates opportunities. Our overbought reading is heating up, suggesting you proactively pick entry points.
- 07/24/2020
|
Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2020
- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2020 on Wednesday, August 5, 2020, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Dan Chard, Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
- 07/22/2020
|
Looking for a Growth Stock? 3 Reasons Why Medifast (MED) is a Solid Choice
- Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- 07/22/2020
|
Will Medifast Continue to Surge Higher?
- As of late, it has definitely been a great time to be an investor of Medifast
- 07/21/2020
|
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
- Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
- 07/21/2020
|
Medifast, Inc. Names Jim Maloney as Chief Financial Officer
- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced that it has appointed James (Jim) Maloney as Chief Financial Officer, effective July 20, 2020. In his role, Mr. Maloney will be responsible for leading the finance function including all aspects of financial planning and analysis, setting Medifast's financial and capital allocation strategies, and managing investor relations. He will serve as a member of the company's leadership team and report directly to Chief Executive Officer Dan Chard.
- 07/20/2020
|
Parallel Advisors LLC Acquires New Position in Medifast Inc (NYSE:MED)
- Parallel Advisors LLC acquired a new stake in Medifast Inc (NYSE:MED) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 3,705 shares of the specialty retailer’s stock, valued at approximately $514,000. A number of other institutional investors have also recently made changes to their positions in MED. […]
- 07/19/2020
|
Mednax, Accolade See Activist Actions
- Starboard Value increased its position in pediatric and neonatal health-services firm Mednax. Carrick Management Partners disclosed an initial investment of 3,508,278 shares in Accolade, a newly public workplace health-benefits manager.
- 07/18/2020
|
Can Medifast (MED) Keep the Earnings Surprise Streak Alive?
- Medifast (MED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/17/2020
|
|
|
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 07/16/2020
|
Silver Ring Value Partners Q2 2020 Letter
- Silver Ring Value Partners utilizes a concentrated intrinsic value approach in seeking to safely compound capital over the long term.
- 07/14/2020
|
Medifast Survey Finds 88% of People Experiencing Stress During Pandemic
- Nearly nine out of ten U.S. adults (88 percent) report experiencing stress during the pandemic, according to a survey conducted by Medifast (NYSE: MED), the company behind OPTAVIA®, one of the fastest-growing health and wellness communities. Additionally, 82 percent of those surveyed are concerned about at least one aspect of their physical or mental health, and one-fifth are struggling to make progress on their pre-pandemic health goals.
- 07/13/2020
|
Top Stocks To Buy On A Sell-Off
- Let your winners continue winning, but begin compiling a watch list to buy on a pullback. These top-ranked industries are the best hunting ground for ideas.
- 07/13/2020
|
5 DuPont-Tested Winning Stocks
- Use the DuPont technique to pick solid profit-generating stocks.
- 07/03/2020
|
Packaged Food Demand Grows as Coronavirus Fears Spike: 4 Winners
- An increasing number of people are opting for comfort food at home given that most restaurants and cafes remain closed.
- 06/30/2020
|
B. Riley Weighs in on Medifast Inc’s Q2 2020 Earnings (NYSE:MED)
- Medifast Inc (NYSE:MED) – Equities researchers at B. Riley issued their Q2 2020 earnings estimates for Medifast in a research report issued on Wednesday, June 24th. B. Riley analyst K. Anderson expects that the specialty retailer will post earnings of $1.81 per share for the quarter. B. Riley has a “Buy” rating and a $164.00 […]
- 06/30/2020
|
Moving Average Crossover Alert: Medifast
- Medifast, Inc. (MED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- 06/29/2020
|
MEDIFAST, INC. : Ex-dividend day for | MarketScreener
|
MEDIFAST, INC. : Détachement de dividende | Zone bourse
|
Brokerages Set Medifast Inc (NYSE:MED) PT at $112.50
- Medifast Inc (NYSE:MED) has been given a consensus rating of “Hold” by the six analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and one has given a strong buy rating […]
- 06/28/2020
|
Is Medifast, Inc. (MED) A Good Stock To Buy?
- Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- 06/27/2020
|
Don't Buy Falling Financials, Buy These Stocks Instead
- Stress test results put the brakes on banking stocks. Healthcare and technology are better sectors for alpha-generating ideas. Top stocks to add to watch lists
- 06/27/2020
|
Don't Buy Falling Financials, Buy These Stocks Instead
- Stress test results put the brakes on banking stocks. Healthcare and technology are better sectors for alpha-generating ideas. Top stocks to add to watch lists
- 06/26/2020
|
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
- The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
- 06/26/2020
|
Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 06/25/2020
|
Benzinga's Top Upgrades, Downgrades For June 25, 2020
- Upgrades * Credit Suisse changed the rating for Allstate Corp (NYSE: ALL) from Underperform to Neutral. Allstate earned $3.54 in the first quarter, compared to $2.30 in the year-ago quarter. The stock has a 52-week-high of $125.92 and a 52-week-low of $64.13. Allstate's stock last closed at $92.96 per share. * SunTrust Robinson Humphrey upgraded the stock for Diamondback Energy Inc (NASDAQ: FANG) from Hold to Buy. For the first quarter, Diamondback Energy had an EPS of $1.45, compared to year-ago quarter EPS of $1.39. The stock has a 52-week-high of $111.84 and a 52-week-low of $14.55. Diamondback Energy's stock last closed at $41.90 per share. * Goldman Sachs changed the rating for Ameriprise Financial Inc (NYSE: AMP) from Neutral to Buy. For the first quarter, Ameriprise Financial had an EPS of $5.41, compared to year-ago quarter EPS of $3.75. The stock has a 52-week-high of $180.85 and a 52-week-low of $80.01. Ameriprise Financial's stock last closed at $142.90 per share. * Stifel upgraded the stock for AeroVironment Inc (NASDAQ: AVAV) from Hold to Buy. AeroVironment earned $0.75 in the fourth quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $79.54 and a 52-week-low of $45.00. AeroVironment's stock last closed at $71.80 per share. * Baird changed the rating for Fortive Corp (NYSE: FTV) from Neutral to Outperform. For the first quarter, Fortive had an EPS of $0.74, compared to year-ago quarter EPS of $0.69. The stock has a 52-week-high of $83.18 and a 52-week-low of $37.31. Fortive's stock last closed at $66.02 per share. * Goldman Sachs upgraded the stock for Patterson Companies Inc (NASDAQ: PDCO) from Sell to Neutral. Patterson Companies earned $0.43 in the fourth quarter, compared to $0.37 in the year-ago quarter. The stock has a 52-week-high of $25.70 and a 52-week-low of $12.93. Patterson Companies's stock last closed at $20.03 per share. Downgrades * Oppenheimer changed the rating for iQIYI Inc (NASDAQ: IQ) from Outperform to Perform. In the first quarter, iQIYI showed an EPS of ($0.56), compared to ($0.35) from the year-ago quarter. The stock has a 52-week-high of $27.50 and a 52-week-low of $14.51. iQIYI's stock last closed at $22.92 per share. * Berenberg changed the rating for Boeing Co (NYSE: BA) from Hold to Sell. For the first quarter, Boeing had an EPS of ($1.70), compared to year-ago quarter EPS of $3.16. The stock has a 52-week-high of $391.00 and a 52-week-low of $89.00. Boeing's stock last closed at $176.79 per share. * BMO Capital downgraded the stock for Century Aluminum Co (NASDAQ: CENX) from Outperform to Market Perform. Century Aluminum earned $0.01 in the first quarter, compared to ($0.70) in the year-ago quarter. The stock has a 52-week-high of $8.42 and a 52-week-low of $2.91. Century Aluminum's stock last closed at $6.91 per share. * For GrubHub Inc (NYSE: GRUB), Canaccord Genuity downgraded the stock from Buy to Hold. In the first quarter, GrubHub showed an EPS of $0.00, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $80.25 and a 52-week-low of $29.35. GrubHub's stock last closed at $68.36 per share. * Wells Fargo changed the rating for Marathon Oil Corp (NYSE: MRO) from Overweight to Equal-Weight. Marathon Oil earned ($0.16) in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $14.70 and a 52-week-low of $3.02. Marathon Oil's stock last closed at $5.78 per share. * Wells Fargo changed the rating for uniQure NV (NASDAQ: QURE) from Overweight to Equal-Weight. For the first quarter, uniQure had an EPS of ($0.63), compared to year-ago quarter EPS of ($0.74). The stock has a 52-week-high of $79.97 and a 52-week-low of $36.20. uniQure's stock last closed at $62.91 per share. * Goldman Sachs downgraded the stock for SolarEdge Technologies Inc (NASDAQ: SEDG) from Neutral to Sell. In the first quarter, SolarEdge Technologies showed an EPS of $0.95, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $156.92 and a 52-week-low of $58.84. SolarEdge Technologies's stock last closed at $148.48 per share. * For Vivint Solar Inc (NYSE: VSLR), Goldman Sachs downgraded the stock from Buy to Neutral. For the first quarter, Vivint Solar had an EPS of ($0.32), compared to year-ago quarter EPS of ($0.22). The stock has a 52-week-high of $12.99 and a 52-week-low of $3.17. Vivint Solar's stock last closed at $10.04 per share. Initiations * B of A Securities initiated coverage on BridgeBio Pharma Inc (NASDAQ: BBIO) with a Neutral rating. The price target for BridgeBio Pharma is set at $38.00. In the first quarter, BridgeBio Pharma showed an EPS of ($0.78), compared to ($0.66) from the year-ago quarter. The stock has a 52-week-high of $48.36 and a 52-week-low of $14.23. BridgeBio Pharma's stock last closed at $32.96 per share. * With a rating of Buy, B of A Securities initiated coverage on NeoGenomics Inc (NASDAQ: NEO). The price target is set at $34.00 for NeoGenomics. In the first quarter, NeoGenomics showed an EPS of ($0.02), compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $34.97 and a 52-week-low of $18.52. NeoGenomics's stock last closed at $27.78 per share. * B of A Securities initiated coverage on Athersys Inc (NASDAQ: ATHX) with a Buy rating. The price target for Athersys is set at $5.00. In the first quarter, Athersys showed an EPS of ($0.10), compared to ($0.09) from the year-ago quarter. The stock has a 52-week-high of $4.38 and a 52-week-low of $1.13. Athersys's stock last closed at $2.22 per share. * Berenberg initiated coverage on Splunk Inc (NASDAQ: SPLK) with a Buy rating. The price target for Splunk is set at $222.00. For the first quarter, Splunk had an EPS of ($0.56), compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $197.22 and a 52-week-low of $93.92. Splunk's stock last closed at $190.61 per share. * HC Wainwright & Co. initiated coverage on Intercept Pharmaceuticals Inc (NASDAQ: ICPT) with a Neutral rating. The price target for Intercept Pharmaceuticals is set at $92.00. For the first quarter, Intercept Pharmaceuticals had an EPS of ($2.86), compared to year-ago quarter EPS of ($3.03). The stock has a 52-week-high of $125.00 and a 52-week-low of $47.57. Intercept Pharmaceuticals's stock last closed at $78.16 per share. * With a rating of Buy, HC Wainwright & Co. initiated coverage on Flexion Therapeutics Inc (NASDAQ: FLXN). The price target is set at $25.00 for Flexion Therapeutics. In the first quarter, Flexion Therapeutics showed an EPS of ($0.95), compared to ($1.09) from the year-ago quarter. The stock has a 52-week-high of $22.98 and a 52-week-low of $5.01. Flexion Therapeutics's stock last closed at $12.09 per share. * With a rating of Outperform, Oppenheimer initiated coverage on DocuSign Inc (NASDAQ: DOCU). The price target is set at $200.00 for DocuSign. For the first quarter, DocuSign had an EPS of $0.12, compared to year-ago quarter EPS of $0.07. The stock has a 52-week-high of $172.21 and a 52-week-low of $43.13. DocuSign's stock last closed at $163.91 per share. * With a rating of Outperform, SMBC Nikko initiated coverage on Inphi Corp (NYSE: IPHI). The price target is set at $140.00 for Inphi. Inphi earned $0.62 in the first quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $127.78 and a 52-week-low of $48.30. Inphi's stock last closed at $109.23 per share. * With a rating of Buy, B. Riley FBR initiated coverage on Medifast Inc (NYSE: MED). The price target is set at $164.00 for Medifast. In the first quarter, Medifast showed an EPS of $1.93, compared to $1.70 from the year-ago quarter. The stock has a 52-week-high of $130.99 and a 52-week-low of $49.03. Medifast's stock last closed at $122.94 per share. * Wells Fargo initiated coverage on MKS Instruments Inc (NASDAQ: MKSI) with a Equal-Weight rating. The price target for MKS Instruments is set at $120.00. For the first quarter, MKS Instruments had an EPS of $1.54, compared to year-ago quarter EPS of $1.12. The stock has a 52-week-high of $122.30 and a 52-week-low of $66.87. MKS Instruments's stock last closed at $112.83 per share. * Wells Fargo initiated coverage on Range Resources Corp (NYSE: RRC) with a Equal-Weight rating. The price target for Range Resources is set at $11.00. For the first quarter, Range Resources had an EPS of $0.04, compared to year-ago quarter EPS of $0.36. The stock has a 52-week-high of $8.25 and a 52-week-low of $1.61. Range Resources's stock last closed at $5.59 per share. * Stephens & Co. initiated coverage on SmileDirectClub Inc (NASDAQ: SDC) with an Overweight rating. The price target for SmileDirectClub is set at $11.00. Interestingly, in the first quarter, SmileDirectClub's EPS was ($0.28). The stock has a 52-week-high of $21.10 and a 52-week-low of $3.64. SmileDirectClub's stock last closed at $7.14 per share. * Baird initiated coverage on Albireo Pharma Inc (NASDAQ: ALBO) with an Outperform rating. The price target for Albireo Pharma is set at $52.00. In the first quarter, Albireo Pharma showed an EPS of ($2.23), compared to ($1.39) from the year-ago quarter. The stock has a 52-week-high of $32.49 and a 52-week-low of $11.26. Albireo Pharma's stock last closed at $26.61 per share. * With a rating of Buy, MKM Partners initiated coverage on Talos Energy Inc (NYSE: TALO). The price target is set at $17.00 for Talos Energy. Talos Energy earned $0.27 in the first quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $31.34 and a 52-week-low of $5.00. Talos Energy's stock last closed at $9.15 per share.See more from Benzinga * Enerpac Tool Group: Q3 Earnings Insights * 10 Technology Stocks Moving In Thursday's Pre-Market Session * 11 Energy Stocks Moving In Thursday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 06/25/2020
|
B.Riley FBR Believes Medifast (NYSE: MED) Won't Stop Here - Markets
- In a report released yesterday, Kara Anderson from B.Riley FBR initiated coverage with a Buy rating on Medifast (MED –
- 06/25/2020
|
Balyasny Asset Management LLC Purchases New Holdings in Medifast Inc (NYSE:MED)
- Balyasny Asset Management LLC purchased a new stake in shares of Medifast Inc (NYSE:MED) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 4,587 shares of the specialty retailer’s stock, valued at approximately $287,000. Several other institutional investors and hedge funds have also modified their […]
- 06/25/2020
|
Quality Compounders: 2 Ways To Invest In The Highest-Quality Public Companies In America
- We study the highest-quality public companies in America. Currently 39 qualify. In this report, we identify the leaders in each major category: financial statem
- 06/22/2020
|
The Best Stocks To Buy On Down Days
- Risk/reward shifts back to neutral, suggesting volatility will continue through the end of the quarter. Healthcare and technology are top sectors to buy on sale
- 06/21/2020
|
Dividend Challenger Highlights: Week Of June 21
|
Deutsche Bank AG Increases Position in Medifast Inc (NYSE:MED)
- Deutsche Bank AG grew its stake in Medifast Inc (NYSE:MED) by 32.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 98,986 shares of the specialty retailer’s stock after acquiring an additional 24,221 shares during the quarter. Deutsche Bank AG owned about 0.84% of […]
- 06/20/2020
|
Parametric Portfolio Associates LLC Has $5.82 Million Holdings in Medifast Inc (NYSE:MED)
- Parametric Portfolio Associates LLC lessened its stake in Medifast Inc (NYSE:MED) by 18.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 93,050 shares of the specialty retailer’s stock after selling 21,518 shares during the quarter. Parametric Portfolio Associates LLC owned about 0.79% […]
- 06/20/2020
|
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
- The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
- 06/18/2020
|
5 Consumer Staple Dividend Stocks to Enrich Your Portfolio
- At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.
- 06/17/2020
|
Medifast, Inc. Announces Quarterly Dividend
- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of Directors has declared a $1.13 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.13 per share is payable on August 6, 2020 to stockholders of record as of the close of business on June 30, 2020.
- 06/16/2020
|
Medifast Scores Relative Strength Rating Upgrade; Hits Key Benchmark
- On Monday, Medifast got an upgrade to its Relative Strength (RS) Rating, from 80 to 86. When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength. IBD's proprietary rating identifies price movement with a 1 (worst) to 99 (best) score.
- 06/15/2020
|
Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why
- Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- 06/15/2020
|
The Top Stocks To Buy On A Crash
- Growing volatility creates opportunities in the best stocks and sectors. Healthcare and technology remain top sectors to buy. Here are the best stocks to buy in
- 06/12/2020
|
Will Medifast Continue to Surge Higher?
- As of late, it has definitely been a great time to be an investor of Medifast
- 06/11/2020
|
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
- Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- 06/09/2020
|
U.S. Job Losses See Revival in May: Here's What It Means
- The job market is on the mend as lockdowns are eased and businesses gradual reopen. May numbers surpass all expectations, indicating the start of an economic revival from the coronavirus crisis.
- 06/08/2020
|
52 Super Deals and Discounts for 2020
- With a special nod to those of you spending more time at home, we found dozens of deals and discounts, plus ways to save (or make) money.
- 06/06/2020
|
The Strongest Stocks To Buy Now
- Risk of a 3% to 5% correction is increasing. Here's what you can do to position yourself now. The best sectors and stocks to buy.
- 06/06/2020
|
Zacks.com featured highlights include: BWX Technologies, Murphy USA, Dollar General and Medifast
- Zacks.com featured highlights include: BWX Technologies, Murphy USA, Dollar General and Medifast
- 06/05/2020
|
Surging Earnings Estimates Signal Good News for Medifast (MED)
- Medifast (MED) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
- 06/04/2020
|
4 Top-Ranked Picks Using DuPont Analysis for Solid Returns
- Have more faith in DuPont analysis than simple ROE calculation? Bet on these stocks.
- 06/04/2020
|
4 Top Momentum Stocks Powered by Driehaus Strategy
- Investors who have the propensity to take higher risk can think of investing in momentum stocks to boost their gains.
- 06/04/2020
|
Top Ranked Momentum Stocks to Buy for June 3rd
- Top Ranked Momentum Stocks to Buy for June 3rd
- 06/03/2020
|
Zacks.com featured highlights include: eXp World, Dropbox, Medifast and Logitech International
- Zacks.com featured highlights include: eXp World, Dropbox, Medifast and Logitech International
- 06/02/2020
|
Top Ranked Income Stocks to Buy for June 1st
- Top Ranked Income Stocks to Buy for June 1st
- 06/01/2020
|
Organic Cereals Market Size Rising at 9.2% CAGR During 2019-2026: Analysis of Key Players, Trends and Drivers
- Jun 01, 2020 (Market Insight Reports) --
Selbyville, Delaware, Market Study Report LLC: The Report 2019-2026 Global Organic Cereals Market Report explores...
- 06/01/2020
|
Are Investors Undervaluing Medifast (MED) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/29/2020
|
Medifast, A Strong Strategy And Double-Digit EBIT Margins (NYSE:MED)
- My estimated CAGR for the global weight management industry between 2019 and 2024 is 3.0%, ending with a value of $235 billion. Medifast was able to grow its sa
- 05/28/2020
|
A Trio of Potentially Underestimated Stocks to Consider
- 2 key valuation ratios may signal potential bargains Continue reading...
- 05/28/2020
|
Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why
- Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 05/28/2020
|
Top Ranked Income Stocks to Buy for May 28th
- Top Ranked Income Stocks to Buy for May 28th
- 05/28/2020
|
Consumer Confidence Rebounds in May: 5 Winners
- A massive $3 trillion rescue fund, hopes of a COVID-19 vaccine and reopening of businesses are helping consumers regain their lost confidence.
- 05/27/2020
|
Edited Transcript of MED earnings conference call or presentation 5-May-20 8:30pm GMT
- Q1 2020 Medifast Inc Earnings Call
- 05/26/2020
|
Edited Transcript of MED earnings conference call or presentation 5-May-20 8:30pm GMT
- Q1 2020 Medifast Inc Earnings Call
- 05/23/2020
|
Medifast Can Help With Your Diet - But Maybe Not Your Portfolio
- Callers get a shot at asking Jim Cramer about companies that they are interested in. In the daily bar chart of MED, below, we can see that prices have been in a downtrend the past 12 months. Prices have doubled from their March low but we haven't broken above the January peak so technically we are still in a downtrend.
- 05/22/2020
|
Why Medifast (MED) Stock Might be a Great Pick
- Medifast (MED) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 05/21/2020
|
The Zacks Analyst Blog Highlights: Equinox Gold, Medifast, NeoPhotonics, Veritiv and Tutor Perini
- The Zacks Analyst Blog Highlights: Equinox Gold, Medifast, NeoPhotonics, Veritiv and Tutor Perini
- 05/20/2020
|
6 Stocks with Improving Prospects
- These 6 stocks are good opportunities, no matter how you look at them.
- 05/19/2020
|
Medifast, Inc. (MED) Shares March Higher, Can It Continue?
- As of late, it has definitely been a great time to be an investor in Medifast, Inc. (MED).
- 05/13/2020
|
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- 05/12/2020
|
Are Investors Undervaluing Medifast (MED) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/11/2020
|
Fast Sales Growth Continues For Medifast
- Medifast organic sales have grown by more than 40% each year for the past two years. The Medifast team has successfully navigate past economic crisis. In my opi
- 05/11/2020
|
New Strong Buy Stocks for May 11th
- New Strong Buy Stocks for May 11th
- 05/11/2020
|
Were Hedge Funds Right About Medifast, Inc. (MED)?
- Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […]
- 05/10/2020
|
Medifast: A Value Play Also Offering Safe Income Generation
- Selling naked, or cash-secured puts, in this volatile environment can be very profitable. However, you must choose a value stock selling at a discount. Medifast
- 05/08/2020
|
How Does Medifast's (NYSE:MED) P/E Compare To Its Industry, After Its Big Share Price Gain?
- Those holding Medifast (NYSE:MED) shares must be pleased that the share price has rebounded 38% in the last thirty...
- 05/07/2020
|
Medifast (MED) Q1 2020 Earnings Call Transcript
- On the call with me today are Dan Chard, chief executive officer, and Joe Kelleman, interim chief financial officer. If you've not received the release, it is available on the investor relations portion of Medifast's website at www.medifastinc.com. Before we begin, we'd like to remind everyone that the prepared remarks contain forward-looking statements and management may make additional forward-looking statements in response to your questions.
- 05/06/2020
|
Medifast (MED) Beats Q1 Earnings and Revenue Estimates
- Medifast (MED) delivered earnings and revenue surprises of 46.21% and 10.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2020
|
Medifast, Inc. Announces First Quarter 2020 Financial Results
- Medifast (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the first quarter ended March 31, 2020.
- 05/05/2020
|
Investors Purchase High Volume of Put Options on Medifast (NYSE:MED)
- Medifast Inc (NYSE:MED) was the target of some unusual options trading on Thursday. Stock traders bought 6,815 put options on the company. This is an increase of approximately 3,055% compared to the typical volume of 216 put options. MED stock opened at $73.30 on Friday. Medifast has a fifty-two week low of $49.03 and a […]
- 05/02/2020
|
Stock Traders Buy Large Volume of Medifast Call Options (NYSE:MED)
- Medifast Inc (NYSE:MED) was the recipient of some unusual options trading on Thursday. Stock traders purchased 7,104 call options on the stock. This is an increase of 1,362% compared to the typical daily volume of 486 call options. MED has been the topic of several research reports. Jefferies Financial Group downgraded Medifast from a “buy” […]
- 05/01/2020
|
ARP Americas LP Invests $206,000 in Medifast Inc (NYSE:MED)
- ARP Americas LP purchased a new position in Medifast Inc (NYSE:MED) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,300 shares of the specialty retailer’s stock, valued at approximately $206,000. Several other institutional investors have also recently added to […]
- 05/01/2020
|
Does Medifast (NYSE:MED) Deserve A Spot On Your Watchlist?
- Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
- 04/30/2020
|
Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for
- Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for
- Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Why Silver Ring Value Partners is Bullish on Berkshire Hathaway and Medifast
- Silver Ring Value Partners LP is a Boston-based investment management firm that specializes in delivering long-term value by utilizing an intrinsic and robust approach to investing. The company was founded in 2016 by Chief Investment Officer and Managing Partner Gary Mishuris. Recently, Silver Ring Value Partners released its Q1 2020 Investor Letter – a copy […]
- 04/24/2020
|
Short Interest in Medifast Inc (NYSE:MED) Drops By 7.4%
- Medifast Inc (NYSE:MED) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 3,320,000 shares, a decline of 7.4% from the March 15th total of 3,583,600 shares. Currently, 29.6% of the company’s shares are short sold. Based on an average daily trading volume, of […]
- 04/23/2020
|
Medifast (NYSE:MED) Stock Rating Lowered by Zacks Investment Research
- Medifast (NYSE:MED) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, […]
- 04/22/2020
|
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2020
- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, will announce financial results for the first quarter ended March 31, 2020 on Tuesday, May 5, 2020, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Dan Chard, Chief Executive Officer, and Joe Kelleman, Interim Chief Financial Officer.
- 04/21/2020
|
Our Picks of High-Quality Fast Growers
- One of Peter Lynch’s favorite categories Continue reading...
- 04/21/2020
|
Our Picks of High-Quality Fast Growers
- Our Picks of High-Quality Fast Growers, Stocks: LSE:FEVR,WAR:LVC,OSTO:EVO,ASX:A2M,MED,SLP,LSE:PLUS, release date:Apr 21, 2020
- 04/21/2020
|
Top Ranked Income Stocks to Buy for April 20th
- Top Ranked Income Stocks to Buy for April 20th
- 04/20/2020
|
Top Ranked Income Stocks to Buy for April 20th
- Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 20th.
- 04/20/2020
|
Does The Medifast, Inc. (NYSE:MED) Share Price Fall With The Market?
- Anyone researching Medifast, Inc. (NYSE:MED) might want to consider the historical volatility of the share price...
- 04/20/2020
|
Medifast, Inc. (NYSE:MED): Has Recent Earnings Growth Beaten Long-Term Trend?
- Investors with a long-term horizong may find it valuable to assess Medifast, Inc.'s (NYSE:MED) earnings trend over...
- 04/20/2020
|
Norges Bank Invests $15.23 Million in Medifast Inc (NYSE:MED)
- Norges Bank bought a new position in shares of Medifast Inc (NYSE:MED) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 138,958 shares of the specialty retailer’s stock, valued at approximately $15,227,000. A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Verus Capital Partners LLC […]
- 04/20/2020
|
Q1 2020 EPS Estimates for Medifast Inc Reduced by Analyst (NYSE:MED)
- Medifast Inc (NYSE:MED) – Analysts at Jefferies Financial Group lowered their Q1 2020 earnings per share estimates for shares of Medifast in a research report issued to clients and investors on Friday, April 17th. Jefferies Financial Group analyst S. Wissink now forecasts that the specialty retailer will post earnings per share of $1.21 for the […]
- 04/20/2020
|
Stock Traders Buy Large Volume of Put Options on Medifast (NYSE:MED)
- Medifast Inc (NYSE:MED) saw unusually large options trading activity on Tuesday. Traders bought 1,263 put options on the company. This is an increase of approximately 1,607% compared to the average volume of 74 put options. Institutional investors have recently added to or reduced their stakes in the company. Quadrant Capital Group LLC bought a new […]
- 04/15/2020
|
2,530 Shares in Medifast Inc (NYSE:MED) Bought by Franklin Resources Inc.
- Franklin Resources Inc. purchased a new position in Medifast Inc (NYSE:MED) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 2,530 shares of the specialty retailer’s stock, valued at approximately $277,000. Several other hedge funds and other institutional investors also recently added to […]
- 04/15/2020
|
618 Shares in Medifast Inc (NYSE:MED) Acquired by Carroll Financial Associates Inc.
- Carroll Financial Associates Inc. purchased a new stake in Medifast Inc (NYSE:MED) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 618 shares of the specialty retailer’s stock, valued at approximately $38,000. Other hedge funds and other institutional investors also recently bought and sold […]
- 04/14/2020
|
Alliancebernstein L.P. Has $2.82 Million Stock Position in Medifast Inc (NYSE:MED)
- Alliancebernstein L.P. decreased its stake in shares of Medifast Inc (NYSE:MED) by 23.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,718 shares of the specialty retailer’s stock after selling 7,850 shares during the period. Alliancebernstein L.P. owned 0.22% […]
- 04/14/2020
|
Forget About Juicy Dividend Yields
- The Fed drives credit spreads even lower. Income investors are again forced to look for yield in equities. Seek safety in dividend payers, but not high dividend
- 04/13/2020
|
Medifast (NYSE:MED) Rating Lowered to Hold at Zacks Investment Research
- Medifast (NYSE:MED) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Saturday, Zacks.com reports. According to Zacks, “Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, distributes, […]
- 04/11/2020
|
FNY Investment Advisers LLC Buys Shares of 2,730 Medifast Inc (NYSE:MED)
- FNY Investment Advisers LLC bought a new stake in shares of Medifast Inc (NYSE:MED) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,730 shares of the specialty retailer’s stock, valued at approximately $170,000. Other institutional investors and hedge funds also recently made changes to […]
- 04/10/2020
|
Bank of America Corp DE Has $7.30 Million Stock Holdings in Medifast Inc (NYSE:MED)
- Bank of America Corp DE boosted its stake in shares of Medifast Inc (NYSE:MED) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 66,601 shares of the specialty retailer’s stock after purchasing an additional 1,402 shares during the period. Bank of America Corp DE […]
- 04/10/2020
|
Medifast (NYSE:MED) Raised to Buy at Zacks Investment Research
- Medifast (NYSE:MED) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday, Zacks.com reports. The firm currently has a $75.00 price target on the specialty retailer’s stock. Zacks Investment Research‘s price target indicates a potential upside of 9.01% from the stock’s previous close. According to […]
- 04/10/2020
|
Investors Who Bought Medifast (NYSE:MED) Shares Five Years Ago Are Now Up 107%
- Medifast, Inc. (NYSE:MED) shareholders might understandably be very concerned that the share price has dropped 43% in...
- 04/07/2020
|
AQR Capital Management LLC Sells 76,992 Shares of Medifast Inc (NYSE:MED)
- AQR Capital Management LLC trimmed its stake in Medifast Inc (NYSE:MED) by 87.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,853 shares of the specialty retailer’s stock after selling 76,992 shares during the period. AQR Capital Management LLC owned […]
- 04/07/2020
|
Bank of New York Mellon Corp Boosts Stake in Medifast Inc (NYSE:MED)
- Bank of New York Mellon Corp increased its stake in shares of Medifast Inc (NYSE:MED) by 28.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 250,930 shares of the specialty retailer’s stock after purchasing an additional 56,297 shares during the period. Bank of New York Mellon […]
- 04/04/2020
|
How Greater Baltimore stocks fared during a tumultuous first quarter
- Legg Mason was Greater Baltimore's only public company to raise its stock price during a tumultuous first quarter.
- 04/03/2020
|
Envestnet Asset Management Inc. Has $313,000 Stock Holdings in Medifast Inc (NYSE:MED)
- Envestnet Asset Management Inc. reduced its position in shares of Medifast Inc (NYSE:MED) by 32.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,855 shares of the specialty retailer’s stock after selling 1,377 shares during the quarter. Envestnet Asset Management Inc.’s holdings in […]
- 04/01/2020
|
Cubist Systematic Strategies LLC Reduces Holdings in Medifast Inc (NYSE:MED)
- Cubist Systematic Strategies LLC trimmed its position in shares of Medifast Inc (NYSE:MED) by 28.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,597 shares of the specialty retailer’s stock after selling 6,163 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.13% of Medifast […]
- 04/01/2020
|
Medifast Inc (NYSE:MED) Short Interest Update
- Medifast Inc (NYSE:MED) saw a significant decline in short interest during the month of March. As of March 13th, there was short interest totalling 3,583,600 shares, a decline of 5.7% from the February 27th total of 3,800,000 shares. Approximately 31.9% of the shares of the stock are short sold. Based on an average trading volume […]
- 03/30/2020
|
Edited Transcript of MED earnings conference call or presentation 26-Feb-20 9:30pm GMT
- Q4 2019 Medifast Inc Earnings Call
- 03/27/2020
|
Medifast, Inc. (NYSE:MED) Passed Our Checks, And It's About To Pay A US$1.13 Dividend
- Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Medifast...
- 03/26/2020
|
Medifast, Inc. (NYSE:MED) Looks Interesting, And It’s About To Pay A Dividend
- Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Medifast...
- 03/25/2020
|
Medifast (NYSE:MED) Trading Up 17.5%
- Shares of Medifast Inc (NYSE:MED) traded up 17.5% during mid-day trading on Tuesday . The stock traded as high as $66.27 and last traded at $65.60, 378,283 shares changed hands during trading. An increase of 19% from the average session volume of 318,195 shares. The stock had previously closed at $55.81. Several equities research analysts […]
- 03/25/2020
|
U.S. activist investors Land & Buildings, Engaged raise new capital -sources
- Several investors who push management to perform better are trying to raise hund...
- 03/24/2020
|
Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?
- Medifast, Inc. (NYSE:MED), which is in the personal products business, and is based in United States, received a lot...
- 03/23/2020
|
Franklin Resources Inc. Takes $277,000 Position in Medifast Inc (NYSE:MED)
- Franklin Resources Inc. purchased a new stake in shares of Medifast Inc (NYSE:MED) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,530 shares of the specialty retailer’s stock, valued at approximately $277,000. Several other hedge funds and other institutional investors […]
- 03/23/2020
|
Dividend Challenger Highlights: Week Of March 22
- A weekly summary of dividend activity for Dividend Challengers. Companies which declared increased dividends. Companies with upcoming ex-dividend dates. Compani
- 03/21/2020
|
Medifast (NYSE:MED) Hits New 1-Year Low at $49.03
- Medifast Inc (NYSE:MED)’s share price hit a new 52-week low on Thursday . The stock traded as low as $49.03 and last traded at $51.70, with a volume of 126646 shares. The stock had previously closed at $51.98. Several research analysts recently weighed in on MED shares. DA Davidson upped their target price on shares […]
- 03/21/2020
|
STOCKS IN THE NEWS
- NEW YORK (AP) — Changes announced in corporate dividends: INCREASED DIVIDENDS Benchmark Electronics .16 from .15 Cousins Properties .30 from .29 Guaranty Bancshares .19 from .18 Independent Bank Corp .46 from .44 Independent Holdings Co .22 from .20 Medifast Inc 1.13 from .75 UDR Inc .36 from .3425 REDUCED DIVIDENDS RLJ Lodging Trust .01 from .33 OTHER CORPORATE NEWS AND LISTINGS: STOCK SPLITS THIS WEEK Lumos Pharma Inc 1 for 9 reverse split Tellus Corp 2 for 1 ACQUISITIONS AND MERGERS MINIMUM VALUE $350 MILLION Habit Restaurant - Yum! Brands (375M) Pattern Energy Group - Canada Pension Plan Investment (6.1B) NEW STOCK LISTINGS NASDAQ GLOBAL AND GLOBAL SELECT MARKETS California BanCorp STOCKS REMOVED FROM TRADING CORPORATE NAME CHANGES NewLink Genetics Corp to Lumos Pharma Inc Tiberius Corp to International General Insurance Holdings Tiberius Corp warrants to International General Insurance Hldg warrant
- 03/20/2020
|
Great West Life Assurance Co. Can Purchases 318 Shares of Medifast Inc (NYSE:MED)
- Great West Life Assurance Co. Can lifted its position in Medifast Inc (NYSE:MED) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,931 shares of the specialty retailer’s stock after purchasing an additional 318 shares during the quarter. Great West Life Assurance Co. […]
- 03/20/2020
|
Medifast, Inc. Announces Quarterly Dividend
- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of Directors has declared a $1.13 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.13 per share is payable on May 6, 2020 to stockholders of record as of the close of business on March 31, 2020.
- 03/19/2020
|
Citigroup Inc. Trims Position in Medifast Inc (NYSE:MED)
- Citigroup Inc. lessened its stake in shares of Medifast Inc (NYSE:MED) by 33.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,670 shares of the specialty retailer’s stock after selling 3,780 shares during the period. Citigroup Inc. owned 0.07% of Medifast […]
- 03/19/2020
|
NumerixS Investment Technologies Inc Lowers Position in Medifast Inc (NYSE:MED)
- NumerixS Investment Technologies Inc cut its holdings in Medifast Inc (NYSE:MED) by 57.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 904 shares of the specialty retailer’s stock after selling 1,196 shares during the quarter. NumerixS Investment Technologies Inc’s holdings […]
- 03/17/2020
|
Shares of Baltimore-area companies rebound as stock market rallies
- Despite rebounding on March 13, the stock market had its worst week since the 2008 financial crisis.
- 03/13/2020
|
A Sliding Share Price Has Us Looking At Medifast, Inc.'s (NYSE:MED) P/E Ratio
- To the annoyance of some shareholders, Medifast (NYSE:MED) shares are down a considerable 31% in the last month...
- 03/12/2020
|
What Is Medifast’s (NYSE:MED) P/E Ratio After Its Share Price Tanked?
- Unfortunately for some shareholders, the Medifast (NYSE:MED) share price has dived 31% in the last thirty days. That...
- 03/12/2020
|
Medifast Inc (NYSE:MED) Shares Sold by Bank of Montreal Can
- Bank of Montreal Can reduced its position in shares of Medifast Inc (NYSE:MED) by 18.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,057 shares of the specialty retailer’s stock after selling 4,136 shares during the period. Bank […]
- 03/11/2020
|
Have Insiders Been Selling Medifast, Inc. (NYSE:MED) Shares This Year?
- We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
- 03/09/2020
|
Pictet Asset Management Ltd. Buys 200 Shares of Medifast Inc (NYSE:MED)
- Pictet Asset Management Ltd. lifted its stake in Medifast Inc (NYSE:MED) by 0.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 393,748 shares of the specialty retailer’s stock after acquiring an additional 200 shares during the period. Pictet Asset Management […]
- 03/09/2020
|
5,243 Shares in Medifast Inc (NYSE:MED) Acquired by Alphasimplex Group LLC
- Alphasimplex Group LLC acquired a new position in shares of Medifast Inc (NYSE:MED) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 5,243 shares of the specialty retailer’s stock, valued at approximately $575,000. Several other large investors also recently bought and sold shares of MED. […]
- 03/08/2020
|
Medifast Inc (NYSE:MED) Stock Position Raised by KBC Group NV
- KBC Group NV lifted its holdings in shares of Medifast Inc (NYSE:MED) by 7.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,487 shares of the specialty retailer’s stock after buying an additional 1,000 shares during the period. KBC Group NV […]
- 03/08/2020
|
Pacer Advisors Inc. Takes $299,000 Position in Medifast Inc (NYSE:MED)
- Pacer Advisors Inc. acquired a new position in shares of Medifast Inc (NYSE:MED) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,729 shares of the specialty retailer’s stock, valued at approximately $299,000. Several other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. boosted its holdings in Medifast […]
- 03/07/2020
|
Why Buybacks, Buyback Yield And Total Yield Are So Important When Stocks Are Falling
- Buybacks provide real value to shareholders. This article will explain the math of why that's so. I provide four examples of the returns for three theoretical c
- 03/06/2020
|
ARGI Investment Services LLC Buys New Shares in Medifast Inc (NYSE:MED)
- ARGI Investment Services LLC bought a new stake in Medifast Inc (NYSE:MED) in the 4th quarter, Holdings Channel reports. The firm bought 5,648 shares of the specialty retailer’s stock, valued at approximately $568,000. Several other large investors have also recently added to or reduced their stakes in MED. Quadrant Capital Group LLC bought a new […]
- 03/06/2020
|
5 High-Yield Dividend Stocks With Great Buyback Programs
- These dividend stocks offer great income to investors, but their tax-efficient buyback programs make them even better stocks to buy now.
- 03/05/2020
|
Medifast CFO to step down
- Medifast Inc.'s chief financial officer will step down at the end of March after seven years with the company. Timothy G. Robinson will leave his position on March 31, Medifast announced late Wednesday. Robinson joined the Baltimore-based dieting and wellness company in 2013 after 23 years at Canon Business Solutions Inc., a wholly owned subsidiary of Canon U.S.A. Medifast has hired an executive search firm to find Robinson's successor.
- 03/05/2020
|
Medifast Announces Chief Financial Officer Transition
- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Timothy G. Robinson, Chief Financial Officer, will be stepping down from his position at the company on March 31, 2020.
- 03/05/2020
|
Three Greater Baltimore public companies report fourth-quarter profits
- Laureate Education Inc. reported that its profit fell 16% in the fourth quarter to $60.6 million.
- 03/04/2020
|
Comerica Bank Reduces Position in Medifast Inc (NYSE:MED)
- Comerica Bank lessened its stake in shares of Medifast Inc (NYSE:MED) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 10,979 shares of the specialty retailer’s stock after selling 168 shares during the quarter. Comerica Bank’s holdings in Medifast were worth $1,079,000 at the end of the most recent quarter. Other large investors […]
- 03/04/2020
|
Medifast (NYSE:MED) Lowered to Hold at Zacks Investment Research
- Medifast (NYSE:MED) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, […]
- 03/04/2020
|
Medifast (NYSE:MED) Upgraded to Strong-Buy by Zacks Investment Research
- Medifast (NYSE:MED) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The firm presently has a $96.00 target price on the specialty retailer’s stock. Zacks Investment Research‘s target price points to a potential upside of 16.62% from the stock’s […]
- 03/03/2020
|
Edited Transcript of MED earnings conference call or presentation 26-Feb-20 9:30pm GMT
- Q4 2019 Medifast Inc Earnings Call
- 03/02/2020
|
The Extreme Risks of Trading Your Own Retirement Assets - March 02, 2020
- Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
- 03/02/2020
|
The Extreme Risks of Trading Your Own Retirement Assets - March 02, 2020
- Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
- 03/02/2020
|
New Strong Buy Stocks for March 2nd
- New Strong Buy Stocks for March 2nd
- 03/02/2020
|
New Strong Buy Stocks for March 2nd
- Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
- 03/02/2020
|
First Trust Advisors LP Has $614,000 Stake in Medifast Inc (NYSE:MED)
- First Trust Advisors LP trimmed its holdings in Medifast Inc (NYSE:MED) by 65.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,607 shares of the specialty retailer’s stock after selling 10,439 shares during the period. First Trust Advisors […]
- 03/02/2020
|
